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Abstract 
This thesis contains the phytochemical analysis of four medicinal Vernonia species growing 
in Nigeria and used in ethnomedicine to treat a variety of medical conditions.  The four 
Vernonia species studied were Vernonia blumeoides, Vernonia perrottetii, Vernonia ambigua 
and Vernonia glaberrima.  The thesis also contains a comprehensive review of the 
sesquiterpene lactones from the genus Vernonia, their structural diversity and biosynthetic 
considerations.  For each of the plants, the crude extracts and selected compounds were tested 
for their antibacterial activity using the traditional disc diffusion and broth microdilution as 
well as anti-quorum sensing assays. 
Three of the four plants studied yielded sesquiterpene lactones, Vernonia blumeoides yielded 
four novel eudesmanolide sesquiterpene lactones (blumeoidolides A-D), Vernonia perrottettii 
yielded a novel keto-hirsutinolide 13-acetoxy-1(4β),5(6)β-diepoxy-8α-(senecioyloxy)-3-oxo-
1,7(11)-germacradiene-12,6-olide B1 and the known keto-hirsutinolide 13-acetoxy-1,4β-
epoxy-8α-(senecioyloxy)-3-oxo-1,5,7(11)-germacratriene-12,6-olide B2 and Vernonia 
ambigua yielded a novel glaucolide sesquiterpene, 5,6-dehydrobrachycalyxolide.  The 
structures of the sesquiterpenes were determined from their 1H, 13C and 2D NMR spectra 
along with mass spectra.  The crystal structure of one of the eudesmanolide sesquiterpenes 
allowed the configuration of the stereocentres in the molecule to be determined. 
In addition to the sesquiterpene lactones, some common sterols and flavonoids were isolated 
from the plants: stigmasterol was isolated from V. blumeoides, lupeol was isolated from V. 
blumeoides, V. ambigua and V. perrottettii and lupeol acetate from V. ambigua and V. 
perrottetti. The flavonoid apigenin was found in V. blumeoides, V. perrottetti and V. 
glaberrima, luteolin in V. blumeoides and V. perrottetti, velutin in V. perrottetti and V. 
glaberrima and chrysoeriol in V. ambigua and V. glaberrima.  Chrysin was found only in V. 
blumeoides and luteolin 3',4'-dimethyl ether in V. glaberrima. 
Several of the isolated sesquiterpene lactones showed good anti-quorum sensing inhibition 
(QSI).  QSI ≥80% was obtained for blumeoidolide A at a concentration ≥ 0.071 mg mL-1, 
blumeoidolide B (≥ 3.6 mg mL-1) and B1 (1.31 mg mL-1), QSI ≥75% for B2 (0.33 mg mL-1) 
and QSI ≥84% for 5,6-dehydrobrachycalyxolide (2.6 mg mL-1).  The sterols, lupeol and 
lupeol acetate, were also found to have QSI ≥84% at 2.6 mg mL-1.  Molecular docking 
studies carried out on blumeodolides A-D in the binding sites of CviR and CviR' 
(transcription activator proteins) suggested that these molecules are able to bind to certain 
domains in the target protein, thus eliciting an effect. 
The current work adds to the library of sesquiterpene lactones from the genus Vernonia and 











B2 = 13-acetoxy-1,4β-epoxy-8α-(senecioyloxy)-3-oxo-1,5,7(11)-germacratriene-12,6-olide 
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A note on numbering used in the thesis 
 
In each chapter, compounds are numbered using arabic numerals, 1, 2, 3 etc.  In the 
supporting information, the numbers for the compounds in Chapter 3 are preceded by an A, 
Chapter 5 a B and Chapter 6 a C.  Hence, the spectra for a particular compound may appear 
in duplicate in the appendices.  These however are different samples from different plants and 
provide proof of isolation of the compound from the plant.   
 
In the abstract and conclusion, common names are used for compounds where available.  
Where compounds do not have a common name and when the name is too long or 
complicated, a code equivalent to the numbering A1, A2, B1, B2 etc. according to the 
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CHAPTER 1 INTRODUCTION  
1.1 The Genus Vernonia Schreb. (Asteraceae) 
Vernonia is the largest of the ninety-eight (98) genera belonging to the Vernonieae tribe - one 
of the thirteen (13) tribes that constitute the Asteraceae family, representing one of the largest 
families of flowering plants (Keeley and Turner, 1990; Jones, 1977). According to Bremer 
(1994), Vernonia comprises approximately 500 species distributed in tropical regions of the 
world especially Africa and South America. There are approximately 20 species in the USA 
and about 200 species growing in Brazil (Lopes, 1991, Jones, 1977). In West Africa, 60 
species have been reported, of which, 37 were recorded in Nigeria (Hutchinson and Dalziel, 
1963). Vernonia can therefore be described as a pan tropical genus found throughout the 
Americas, Africa and Asia (Craig, 2003). It was speculated that Vernonia had only two 
centers of origin; one in Africa and the other in South America. Similar phytoconstituents 
such as sesquiterpene lactones and flavonoids within species from the two centers support 
their geographical origin (Harborne and Williams, 1977).  
 
Vernonia species are generally perennial trees, shrubs or annual herbs grown across diverse 
ecological environments (Ayodele, 1999).  Several of them are vegetables and used as 
medicinal herbs for the treatment of various human and animal diseases (Yeap et al., 2010). 
Approximately 109 Vernonia species are reportedly used in herbal medicine across the world. 
The use of Vernonia species as potential sources of modern medicine, their biological 
activities (in vitro and in vivo) and toxicity profiling have been reviewed in great detail 
(Toyang and Verpoorte, 2013). 
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Vernonia ambigua Kotschy & Peyr.  
This plant is described as a herb, approximately 18 inches high with mauve coloured flowers 
(Figure 1.1). It is distributed across North tropical Africa and Angola (Hutchinson, 1921). In 
Northern Nigeria, Vernonia ambigua is used as a remedy for cough, fever and malaria (Kunle 
and Egharevba, 2009). 
 
Figure 1.1  V. ambigua in natural habitat 
Photograph by Umar Gallah: Department of Biological Sciences,  
Ahmadu Bello University, Zaria, Nigeria 
 
Vernonia blumeoides: Hook f. 
V. blumeoides is a perennial herb found in abandoned fields across Northern Nigeria. It is 2-4 
feet high with leaves shortly attached to the stems, with purple flower heads (Figure 1.2). It 
is widely used as a remedy for stomach-pain and malaria (Aliyu et al., 2011). 
 
 
Figure 1.2  V. blumeoides in natural habitat 
Photograph by Umar Gallah: Department of Biological Sciences,  
Ahmadu Bello University, Zaria, Nigeria 
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Vernonia glaberrima Welw. ex O. Hoffm. 
V. glaberrima is an erect shrub with a height of 3-4 feet and containing white flower heads. 
Its distribution ranges across grasslands in Guinea to Northern Nigeria, Western Cameroon 
and Central Africa to Angola (Hutchinson, 1921). It is used as an anti-malarial, analgesic, 
anti-inflammatory, and anti-microbial herb (Abdullahi et al., 2015). 
 
Vernonia perrottetii Sch. Bip. ex Walp. 
This plant is an annual herb, 60 cm in height with leaves 1-3 cm long and purple flower 
heads. It is distributed from North to South in tropical Africa. In Northern Nigeria, it is 
commonly found in abandoned fields and widely used as purgative agents for gastrointestinal 
problems (Hutchinson et al., 1963; Burkill, 1985). 
 
1.2 The phytochemistry of Vernonia 
The phytochemistry of the genus Vernonia was probably reported for the first time in 1967 
when vernolide was isolated from Vernonia colorata (Toubiana and Gaudemer, 1967). 
Subsequently, the report of vernolepin and vernomenin from Vernonia hymenolepsis 
(Kupchan et al., 1968) was followed by cytotoxic vernodalin and vernomygdin from 
Vernonia amygdalina (Kupchan et al., 1969). Since then, phytochemical studies on Vernonia 
species increased. Several species across the world were investigated, from which 
triterpenoids, flavonoids, coumarins, steroidal or saponin glycosides, polyacetylenes and 
sesquiterpene lactones (SLs) were reported (Igile et al., 1995; Malafronte et al., 2009; 
Toyang and Verpoote, 2013). Triterpenoids, flavonoids and sesquiterpene lactones are the 
major compounds frequently reported from Vernonia with considerable structural diversity. 
Of the different types of triterpenoids isolated from Vernonia, the oleanane, ursane, 
taraxarane, friedelane and friedoursane types have similar structures differing only in the 
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position of methyl groups and double bonds (Figure 1.3). Lupane type triterpenoids are 
somewhat different from these, having a five-membered ring attached to an isopropyl group. 
Fasciculatol, a triterpenoid containing a dihydrofuran ring, is thus far the only triterpenoid of 
this class isolated from Vernonia (Figure 1.3). However, the most commonly isolated 
triterpenoids from the Vernonia species are lupeol, α-amyrin and β-amyrin (Kiplimo, 2012).  
 
 
Figure 1.3  Triterpenoids of the various skeletal-types isolated from Vernonia species 
 
 
The flavonoids are another class of compounds commonly found in Vernonia and in the 
Asteraceae, in general. Vernonia was found to contain mainly glycosides of luteolin, 
kaempferol, apigenin and quercetin (Figure 1.4). Several O-methylated flavones and 
flavonols are also commonly found in many Vernonia species (Bohm and Stuessy, 2001). 
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African Vernonia species produced mainly flavones while South American species contained 
flavonols or flavones or both (Harborne and Williams, 1977). Flavanones were also reported 
in several species including Vernonia brevifolia, Vernonia hindei and Vernonia syringifolia 
(Bohm and Stuessy, 2001). However, only a few Vernonia species contain alkylcoumarin 
derivatives (Bohlmann and Jakupovic, 1990) (Figure 1.4).  
 
 
Figure 1.4 Flavonoids of the different skeletal types and a coumarin from Vernonia 
 
Sesquiterpene lactones are ubiquitous in most species within Vernonia. As such, they are 
useful as chemotaxonomic markers in the Asteraceae family and an important class of 
secondary metabolites due to their widespread biological activities. Due to differences in 
biosynthetic pathways, there are four major skeletal types of sesquiterpene lactones; 
germacranolides, guiainolides, eudesmanolides and elemanolides (Figure 1.5). The 
germacranolides are the largest and, structurally, most diverse having sub-classes as 
glaucolides, non-glaucolides, hirsutinolides and cardinanolides. Miscellaneous sesquiterpene 
lactones in Vernonia are derived from germacranolides via transformations into 
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bourbonenolides (Bohlmann et al., 1981), vernonallenolides (Jakupovic et al., 1986) and 
potamopholides (Bila et al., 2003) (Figure 1.6).  
 
 
Figure 1.5  Sesquiterpene lactones skeletal types from Vernonia 
 
 
Figure 1.6  Miscellaneous sesquiterpene lactones from Vernonia 
 
The phytochemistry of Vernonia is diverse; however, very little information is known or 
understood about the therapeutic potential of several hundreds of chemical compounds 
isolated from the genus. Of the 103 bioactive compounds from Vernonia, as much as 70% are 
sesquiterpene lactones (Toyang and Verpoote, 2013), emphasising the need to explore the 
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structural diversity of sesquiterpene lactones from Vernonia in the search for new and 
effective lead compounds with potential pharmacological or medicinal value. 
1.3 Antimicrobial drug resistance 
Drug resistant infectious diseases are a public health problem due to increasing incidences of 
multi drug resistance (MDR) pathogens. This situation continues to threaten antimicrobial 
chemotherapy especially in developing countries (WHO, 2014). The search for new 
antibiotics to combat the problem of MDR has therefore intensified in recent years. An 
example of this can be seen in the search for natural compounds effective as inhibitors of 
bacterial efflux pumps (Stavri et al., 2007). Inhibition of bacterial efflux pumps are known to 
inhibit the proliferation of MDR bacteria (Marquez, 2005). Drug combination strategies 
involving plant constituents in combination with antibiotics have demonstrated good activity 
against drug resistant pathogens. Several pure compounds from plant sources have exhibited 
potentiating effects on antibiotics against drug resistant microorganisms (Gibbons, 2005). 
Recent research efforts toward the suppression of bacterial virulence using secondary 
metabolites from plants or microorganisms have proven successful (Teasdale et al., 2009; 
Martín-Rodríguez et al., 2014; Kim Ta and Arnason, 2016). The discovery of antibacterial 
agents with new targets or novel mechanisms, distinct from currently used antibacterial 
drugs, can lead to novel active pharmaceutical ingredients to combat drug resistant pathogens 
(Zhang and Dong, 2004). One such mechanism is quorum sensing (QS), a technique which 
has attracted much interest. 
 
1.4 Quorum sensing  
Quorum sensing (QS) is a bacterial communication system where signal molecules are 
involved in the co-ordination of group behaviour of intercellular bacteria to achieve 
biological functions. In Gram negative bacteria, signal molecules such as acyl homoserine 
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lactones (AHLs) are constantly produced, diffused and accumulated out of the cell. Upon a 
critical threshold concentration or population density, these molecules bind to specific 
receptor proteins of neighbouring bacterial cell walls activating transcription of gene 
expressions used in biofilm formation, resistance production, virulence expressions, 
bioluminescence, motility, swarming and pigment production, among others (Cámara et al., 
2002). Gram positive bacteria such as Staphylococcus aureus have been found to use 
oligopeptide signal molecules to achieve QS (Lyon and Novick, 2004). However, the AHL 
mediated QS systems in Gram -ve bacteria have received greater attention (Geske et al., 
2008) probably since 70 species of Gram -ve bacteria produce AHLs (Surrette and Bassler, 
1998; Atkinson et al., 1999; Smith and Iglewski, 2003).   
 
The AHLs- based QS consist of a four-component circuit: (1) LuxI-type signal synthase, (2) 
AHLs signal molecule, (3) LuxR-type signal receptor and (4) the target genes. The signal 
synthase is an enzyme responsible for the synthesis of AHL-signal molecules at low basal 
concentration; the AHL molecules are fatty acid acyl chains linked through an amide bond to 
homoserine lactones (HSLs), differing in the length and oxidation of the acyl side chain 
(Nisha et al., 2013) (Figure 1.7). The LuxR-type receptor functions as mediator of signal 
molecules to transcriptional regulator, LasR, for activation of gene expression (Pearson et al., 
1997). However, the target genes are intricately related to genes encoding signal synthase, a 
situation that allows for a continuous response system in which signal production and 
dissemination become rapidly enhanced (Hentzer and Givskov, 2003). QS is therefore crucial 
for bacterial cellular functions and survival.  
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Figure 1.7  AHL-QS signal molecules: (a) Pseudomonas aeruginosa: 3-oxo-C12-HSL 
(PAO1), (b) Psedomonas aeruginosa: C4-HSL (PAO2), (c) Agrobacterium tumefaciens: 3-
oxo-C8-HSL and (d) Chromobacterium violaceum C6-HSL. 
 
 
1.5 Biological screening 
Discovery of potential QS inhibitors depend largely on screening methods. Several 
techniques have been developed based on the behaviour of bacterial QS including 
bioluminescence, swarming, motility and pigment production. The commonly used strategy 
involves biosensor strains containing a reporter gene/operon under QS-controlled LuxR-type 
promoter. Chromobacterium violaceum (CV ATCC 12472) is an opportunistic human 
pathogen known to produce purple pigment (due to operon-violacein) under QS-control. A 
mutant of C. violaceum CV026 cannot produce its own AHL signals but can respond to 
exogenous active signal molecules, which interact with CviR to produce purple pigmentation 
(McLean et al., 2004). However, in the presence of QS inhibitors such as plant extracts; 
expression of reporter gene/operon decreases or is completely eliminated. This can be read 
quantitatively as absorbance using spectrophotometry. This inhibition of violacein production 
resulting from loss of purple pigmentation has identified CV organisms as important tools for 
screening QS inhibitors (Adonizio et al., 2006; Rasmussen and Givskov, 2006). CV 
biosensors are however only able to detect AHLs with acyl chains of four to eight carbons in 
length and cannot respond to C4-3-oxo-AHL or AHLs with C10 and longer acyl chains 
(Steindler and Venturi, 2007). This limitation is overcome by using a biosensor with a 
broader range of AHL detection. 
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The AHLs biosensors based on the TraI/R QS system have a broad range of detection with 
significant sensitivity. An example of such a strain is Agrobacterium tumefaciens (Steindler 
and Venturi, 2007).  A. tumefaciens is a plant pathogen with AHLs mediated QS system. The 
strain of A. tumefaciens A136 expresses β-galactosidase under QS control and in response to 
AHL molecules secreted by the AHL over producer KYC6.  In the presence of QS inhibitory 
compounds, a decrease in the formation of β-galactosidase resulting from decreased X-gal 
hydrolysis is indicated by blue pigmentation, qualitatively observed in a double ring assay 
(Chenia, 2013). In AHLs mediated QS systems, the signal vulnerability arising from AHL 
synthesis, dissemination or reception has provided the opportunity to manipulate QS as a 
novel anti-infective strategy.  
 
1.6 Quorum sensing inhibitors from plants 
The search for QS inhibitors from plant sources is attractive due to the numerous plant 
extracts, dietary phytochemicals and essential oils exhibiting QS inhibition (QSI) with 
significant activity (Vattem et al., 2007; Al-Hussaini and Mahasneh, 2009; Szabó et al., 
2010; Koh et al., 2013; Tolmacheva et al., 2014). Since phytochemicals have diverse 
chemical and biological effects on disease therapy, they could also be viable sources of QS 
inhibitors. Presently, the most effective natural QS inhibitors are brominated furanones 
(Figure 1.8) isolated from the marine macro alga Delisea pulchra. Unfortunately, these 
furanones are not suitable as antipathogenic agents due to their toxicity (Manefield et al., 
1999; Bottomley et al., 2007).  
 
Higher plants are a natural reservoir of bioactive compounds and chemical compounds 
isolated from plants are increasingly being identified as potential QS inhibitors. 
Sesquiterpene lactones of the goyazensolide-type isolated from the Argentine Centratherum 
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punctatum demonstrated significant QS inhibitory activity on P. aeruginosa, in vitro (Amaya 
et al., 2012). In addition, the reports indicate that drimane sesquiterpenoids from the Chilean 
Drymys winteri (Paz et al., 2013; Cárcamo et al., 2014), acyl phenol (malabaricone C) from 
the Malaysian Myristica cinnamomea (Chong et al., 2011), iberin (isothiocyanate) from the 
Brassicaceae family (Jakobsen et al., 2012a), ellagic acid derivatives from Terminalia 
chebula (Sarabhai et al., 2013) and ajoene from garlic (Jakobsen et al., 2012b) have 
demonstrated varying degrees of QSI (Dobretsov et al., 2011).  
 
 
Figure 1.8  (a) 4-Bromo-3-butyl-5-dibromomethylene-2(5H)-furanone, (b) 4-Bromo-5-
bromomethylene-3-butyl-2(5H)-furanone  
 
Quorum sensing inhibitors ideally are low molecular weight, stable compounds capable of 
preventing synthesis, accumulation and or signal recognition between QS signals and the 
receptor proteins, in a manner that is target-specific and devoid of toxic side effects on both 
bacteria and the host (Zhang and Dong, 2004; Rasmussen and Givskov, 2006). Because QS 
inhibitory mechanisms involve targeting bacterial signalling to attenuate gene expression 
required by the ‘bacterial quorum’ to establish infections and resistance, it is a radical 
departure from well known mechanisms of targeting cell-walls by antibacterial drugs. In 
addition, QS inhibitors cannot inhibit or kill bacterial cells, unlike antibacterial drugs. Thus, 
the emergence of bacterial resistance to these drugs is not an issue (Hentzer and Givskov, 
2003; Bottomley et al., 2007). Therefore, QSI is an anti-infective strategy with potential to 
provide treatment against bacterial resistance. It is anticipated that chemical compounds from 
12 
indigenous medicinal plants will provide effective, stable and viable leads for the discovery 
and development of antipathogenic drugs.  
 
1.7 Justification for the research 
Plant species used in traditional medicine continue to be reliable sources of new compounds 
for drug discovery. The widely used Vernonia species for treatment of various infectious 
diseases, is a possible source of novel compounds which could be lead compounds in the 
drug discovery programme.  
 
1.8 Aim 
The aim of the present study was to identify bioactive chemical constituents from various 
plant extracts of Vernonia species used in traditional medicine.  
 
1.9 Objectives 
i. To isolate and purify secondary metabolites from four Vernonia species (Vernonia 
ambigua, Vernonia blumeoides, Vernonia glaberrima and Vernonia perrottetii). 
ii. To identify and characterize the structures of the isolated compounds.  
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CHAPTER 2 SESQUITERPENE LACTONES FROM THE GENUS 
VERNONIA (ASTERACEAE): A REVIEW 
 
Abstract  
Sesquiterpene lactones (SLs) have attracted attention in recent years because of their potential 
as lead compounds for the pharmaceutical industry. They have been isolated from the genus 
Vernonia in the last four decades where a variety of skeletal types have been discovered. The 
diversity of the sesquiterpene lactone structure was attributed to plant genetics. There are 309 
sesquiterpene lactones reported to have been isolated from the genus Vernonia.  These are 
largely of the germacranolide, guaianolide, elemanolide and eudesmanolide skeletal types.  
The largest of these is the germacranolide type representing 71%, followed by the 
guaianolides (17%), elemanolides (6%), eudesmanolides (3%) and miscellaneous (3%). This 
review provides an analysis of the chemical and biogenetic relationships of the SLs from 
Vernonia as reported in the literature from 1967 to 2016. 
 
Keywords: Vernonia, sesquiterpene lactones, germacranolides, elemanolides, 




Vernonia belongs to the tribe Vernonieae of the Asteraceae family. It comprises five hundred 
species distributed in tropical regions of the world especially in Africa and South America 
(Bremer, 1994).  There are approximately twenty species in the USA and approximately two 
hundred growing in Brazil (Lopes, 1991; Jones, 1992).  In West Africa, sixty species have 
been reported (Hutchinson and Dalziel, 1963).  Vernonia species are known to synthesise 
terpenoid secondary metabolites such as the sesquiterpene lactones (SLs).  These molecules 
have been isolated from plants over the last four decades.  The structural elucidations of these 
molecules have revealed several classes with enormous chemical and structural diversity.  
This diversity has been linked to plant genetic transformation which suggests that all SLs are 
products of a common biosynthetic origin (Schmidt, 2006).  
 
Phytochemical studies have revealed that the SLs are chemosystematic markers within the 
Asteraceae (Seaman, 1982).  Currently, sesquiterpene lactones isolated from approximately 
eighty one Vernonia species distributed across Africa, the Americas and Asia are documented 
in the literature. They are largely based on the four major skeletal types: elemanolides, 
eudesmanolides, germacranolides and guaianolides. The germacranolides are the largest 
skeletal types consisting of four different subtypes: i. non-glaucolides ii. glaucolides iii. 
hirsutinolides and iv. cardinanolides. However, the eudesmanolides are rarely found and thus 
represent the smallest number in the genus. Miscellaneous SLs with unique ring systems or 
substitutional patterns that are rarely found or less frequently reported also occur. These 
miscellaneous classes are the vernonallenes, bourbonenolides and potamopholide. 
 
This review provides an analysis of the chemical and biogenetic relationships of the SLs from 
Vernonia as reported from 1967 to 2016 and contains structures that were elucidated using 
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NMR spectroscopy. SLs identified by HPLC or mass spectrometry without NMR data were 
not considered in this review.  A total of 309 SLs were reported in 81 Vernonia species across 
53 countries (Table 2.1).  Table 2.1 is arranged with the species in alphabetical order and the 
structures of the compounds can be found in the pages that follow. 
 
Table 2.1  Sesquiterpene lactones isolated from the genus Vernonia 
 
No. Vernonia species Sesquiterpene lactones Reference 
1 V. acunnae 279-282 Budesinky et al. 1993 
2 V. adoensis 44, 63-67 Bohlmann et al. 1984 
3 V. amygdalina 10-11, 13-14, 219-221, 
224, 229-231 
Kupchan et al. 1969; Jisaka et al. 
1993; Sinisi et al. 2015; Asaka et 
al. 1977; Erasto et al. 2006; Luo et 
al. 2011; Toubiana et al. 1975; 
Laekeman et al. 1983 
4 V. angusticeps 239, 251, 262, 263 Budesinky et al. 1993 
5 V. angulifolia 112-116, 131, 133-134 Bohlmann et al. 1978 
6 V. anisochaetoides 252, 264 Bohlmann et al. 1978, 1981b 
7 V. anthelmintica 228, 232, 234-235, 237 Zhang et al. 2014; Ito et al. 2016; 
Liu et al. 2010 
8 V. arborea 265 Kumari et al. 2003 
9 V. arkasana 1-2, 247, 249, 250, 252, 
271, 294-295, 304-308  
Bohlmann et al. 1978; 1981a 
10 V. baldawinii 27 Padolina et al. 1974 
11 V. blumeoides 242-245 Aliyu et al. 2015 
12 V. bockiana 20, 151, 157, 163-164, 
290-292 
Huo et al. 2008 
13 V. brachycalyx 104-105 Oketch-Rabah et al. 1998 
14 V. chinensis 117-119, 125-129 Chen et al. 2005 
15 V. cinerascens 151, 155, 177-179, 182, 
187 
Abdel-Saltar et al. 2000 
16 V. cinerea 42-43, 101, 110-113, 
117-126, 128-132, 134-
135, 155, 158-160, 289 
Jakupovic et al. 1986b; Kou et al. 
2003; Youn et al. 2012, 2014; 
Chen et al. 2006; Chea et al. 2006; 
Zdero et al. 1991 
17 V. cognata 121, 151-152 Bardon et al. 1988 
18 V. colorata 10, 229 Rabe et al. 2002; Chukwujekwu et 
al. 2009  
19 V. compactiflora 199-201 Bohlmann et al. 1982 
20 V. conferta 38 Toubiana et al. 1972 
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No. Vernonia species Sesquiterpene lactones Reference 
21 V. cotoneaster 299-303 Bohlmann et al. 1982; Jakupovic 
et al. 1986b 
22 V. diffusa 282 Jakupovic et al. 1987 
23 V. echitifolia 246 Bohlmann et al. 1978, 1981b 
24 V. erdverbengii 25, 151, 156, 161 Dominguez et al. 1986 
25 V. eremophila 212-216 Alarcon et al. 1990 
26 V. erinaceae 83-84 Tully et al. 1987 
27 V. fasticulata 21, 85 Narain, 1977; 1978 
28 V. fastigiata 96-100 Roos et al. 1998 
29 V. filigera 229 Abegaz et al. 1994 
30 V. fruticulosa 27, 205-207, 211 Bazon et al. 1997 
31 V. fultan 36-37 Bohlmann et al. 1978 
32 V. galamensis 68-76, 94-98, 225 Perdue et al. 1993; Zdero et al. 
1990; Jakupovic et al. 1985 
33 V. gigantea 273-275 Rojas, 2000 
34 V. glabra 7, 18, 219, 224-227, 233, 
236, 295 
Jakupovic et al. 1985; Bohlmann 
et al. 1981b; 1983a 
35 V. greggii 151 Bohlmann et al. 1978 
36 V. guineensis 4, 229, 238 Toyang et al. 2013; Toubiana et 
al. 1975 
37 V. hirsuta 1-2, 8-9, 130, 132, 134, 
252 
Bohlmann et al. 1978; 1981b 
38 V. holstii 99-100 Zdero et al. 1991 
39 V. hymenopsis 224, 236 Kupchan et al. 1968 
40 V. incana 23-24, 60 Bardon et al. 1990 
41 V. jalcana 151, 166-168, 171-172, 
174, 206-210, 293, 286-
287 
Jakupovic et al. 1986b 
42 V. jonesii 15-16 Gershenzon et al. 1984 
43 V. jugalis 148-150 Tsichritzis et al. 1991 
44 V. karuguensis 88 Mungarulire, 1993 
45 V. lanuginosa 29-30 Bohlmann et al.1981a 
46 V. lasiopus 222-223 Koul et al. 2003 
47 V. leopoldii 137, 265, 272, 297 Abegaz et al. 1994; Marzouk et al. 
2016 
48 V. marginata 52-57, 61-62, 91, 203, 
217-218, 283, 288 
Padolina et al. 1974a; Jakupovic et 
al. 1986b; Catalan et al. 1986 
49 V. menthaefolia 209 Budesinky et al. 1993 
50 V. moaensis 1, 162 Budesinky et al. 1993 
51 V. mollissima 
 
157-158, 162 Catalan et al. 1986 
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No. Vernonia species Sesquiterpene lactones Reference 
52 V. natalensis 26, 42, 45, 58, 86-87 Zdero et al. 1991; Bohlmann and 
Zdero, 1982; Bardon and Zdero, 
1982 
53 V. neocorymbosa 6 Bohlmann et al. 1983a 
54 V. nitidula 248, 253-261, 266-270, 
298 
Bardon et al. 1988 
55 V. noveboracensis 22, 190, 247, 276 Padolina et al. 1974b; Bohlmann 
et al. 1978, 1981b 
56 V. nudiflora 28, 33-35, 47-49, 123, 
137-140, 180-181, 183-
188, 210 
Bardon et al. 1992 
57 V. oligocephala 31-32, 44, 59, 136, 277-
278, 296 
Bohlmann et al. 1978; 1984 
58 V. pachyclada 39-40, 46 Williams et al. 2005 
59 V. patens 121, 196, 283-285 Jakupovic et al. 1986a 
60 V. patula 19 Qiao-Li et al. 2010 
61 V. pectoralis 5, 10, 241 McPhail et al. 1975 
62 V. pedunculata 81-82 Lopes, 1991 
63 V. pinguis 123-124, 127, 129-131, 
197-198, 202-204, 240 
Borkosky et al. 1997, Catalan et 
al. 1986 
64 V. polyanthes 151, 175-176, 181-184 Bohlmann et al. 1983b 
65 V. poole 27 Gershenzou et al. 1984 
66 V. poskeana 102-103, 141-146 Bohlmann et al. 1983a; Jakupovic 
et al. 1986a 
67 V. potamophila 309 Bila-Babady et al. 2003 
68 V. profuga 1-2, 247, 271, 295 Bohlmann et al. 1978; 1981a 
69 V. saltens 169-170 Bohlmann et al. 1979 
70 V. saltensis 191-192, 194-195 Bohlmann et al. 1979 
71 V. scorpioides 17, 22-23, 153-154, 162, 
169-170 
Drew et al. 1980; Jakupovic et al. 
1985; Buskuhl et al. 2010, 
Bohlmann et al. 1979 
72 V. squamulosa 151 Catalan et al. 1986 
73 V. staehelionoides 92-93, 142, 146 Bohlmann et al. 1982; Pillay et al. 
2007 
74 V. steetziana 89-90, 141-142, 147 Zdero et al. 1991 
75 V. sutherlandii 58 Bohlmann et al. 1984 
76 V. syringifolia 58, 77-80, 155 Bohlmann et al. 1984; Abegaz et 
al. 1994; Zdero et al. 1991 
77 V. thomsoniana 3 Mungarulire, 1993 
78 V. triflosculosa 165-166, 173 Kos et al. 2006 
79 V. uniflora 
 
41 Taylor and Watson, 1976 
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80 V. vernosissima 152, 185, 191 Bohlmann et al. 1981b 
81 V. zanzibarensis 106-109 Zdero et al. 1991 
 
2.2 Sesquiterpene lactones 
Sesquiterpene lactones consist of C-15 compounds which have at least one lactone (cyclic 
ester) ring in its structure.  For example in costunolide (Figure 2.1), a lactone ring occurs 
usually at C6 and C7 of the cyclodecadiene ring.  In addition, three double bonds are present 
at C-1(10), ∆4 and ∆12 and two methyl groups occur at C-4 and C-10 (Figure 2.1).  
Biogenetic studies of sesquiterpene lactones have indicated that they are derived from the 
mevalonic acid pathway (Craig 2003).  Cyclization of (E,E)-farnesyl pyrophosphate (FPP) 
mediated by germacrane A synthase results in germacrane A, which undergoes several 
oxidation steps and lactonisation to form costunolide, which is regarded as the common 





Figure 2.1  Plausible biosynthetic pathway of sesquiterpene lactones. 1 germacrene A 
synthase, 2-5a oxidations, 5b lactone formation (Majdi et al., 2011).   
2.3 Germacranolides 
Germacranolides are derived from the parent germacrane (Figure 2.1) and characterised by a 
cyclodecadiene skeleton with a C6/C12 γ-lactonized system. They possess an α-methylene-γ-
lactone moiety with β-oriented stereochemistry (Milosavljevi et al., 1999). Since they contain 
two double bonds within the cyclodecadiene ring (Kasymov, 1982), they display structural 
flexibility and can exist as (E,E)-, (Z,E)-, (E,Z)- and (Z,Z)- conformations (Figure 2.2) 
(Minnaard et al., 1999). The predominant conformations are however the (E,E)- and (Z,Z)-
germacranes in sesquiterpene lactones from Vernonia. The germacranolides constitute the 
largest group of sesquiterpene lactones in Vernonia. Their biogenetic formation may involve 
modifications of the basic skeleton by epoxidation, hydroxylation and esterification reactions 
at different positions (Picman, 1981). The germacranolides are further classified into four 
structural sub-types: non-glaucolides, glaucolides, hirsutinolides and cardinanolides based on 
their structural variations. 
 
 
Figure 2.2  Conformational structures of germacrane skeletal types 
 
2.3.1 Non-glaucolides 
These are germacranolides characterized by C6/C12 γ-lactonized systems (Figure 2.3), with 
19 as the only compound bearing a C8/C12 γ-lactone moiety. There are 21 non-glaucolides 
reported from Vernonia, identified by an olefinic methylene group (C-13) and 1(10) and/or ∆4 
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olefinic groups as in costunolide (1). They occur largely in the (E,E)-conformation, except 
artemorin (18) having an exocyclic double bond at C-10. The modifications of costunolide 
involving oxidations and hydroxylation at various positions especially C-8, C-4 and C-10, 
give rise to variety of costunolide derivatives (2-21). The C-8-side chain ester in non-
glaucolides contain a methacryloyl moiety or its derivatives with a few exceptions.  The 
occurrence of sesquiterpene lactone non-glaucolides is poor in the Vernonia genus. However, 
the most representatives are costunolides (1-9) and vernolides (10-14) (Figure 2.4 and 
Figure 2.5). 
 
Figure 2.3  Costunolide type germacranolides  
 





1 Costunolide CH3 CH3 H H C15H20O3 248 
2 Tulipinolide CH3 CH3 O
 







OH  C19H24O6 348 




H C19H22O6 346 
5 Pectorolide CH2OH CH2OH O
 
H C19H24O6 348 




















- - - C20H26O5 346 





Figure 2.4  Vernolide type germacranolides   
 





10 Vernolide OH O
 
CH2 C19H22O7 362 
11 Vernomygdin OH O
 
CH2 C19H24O7 364 










14 14-O-methylvernolide OCH3 O
 
CH2 C20H24O7 376 
 
Biogenetic relations have shown that costunolide (1) is the common precursor to the 
synthesis of the vernolides (10-14). Plausible biosynthetic pathways showed that C14/C15 
oxidative reactions in (1) results in pectrolide (5) which undergoes epoxidation and 
heterocyclic ring formation reactions to form the vernolides (Toubiana et al., 1975) (Figure 
2.5).  
 
Figure 2.5  Plausible biosynthesis of vernolides (10-14) 
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In other non-glaucolide sesquiterpene lactones, oxidations have occurred on the ring and 
hence these compounds contain hydroxyl groups, ketones, epoxides, esters and even sugar 
moieties (15-21) (Figure 2.6a-c). 
 
Figure 2.6a Non-glaucolide germacranolides 
 




15 Keto costunolide C19H24O6 364 
16 Diepoxy costunolide C19H24O6 364 
 
 
Figure 2.6b Non-glaucolide germacranolides (continued) 
 
No. Common name Mol. formula Mol. Mass (g/mol) 
17 Scorpiodine C17H22O4 290 
18 Artemorin C21H26O7 390 




* stereochemistry not indicated in the literature 
 




Common name Mol. formula Mol. mass 
(g/mol) 
20 Taraxinic ester C22H30O9 438 
21 Fasciculide-A         C23H30O9 450 
2.3.2 Glaucolides 
These are a class of sesquiterpene lactones characteristic of the germacranolides. A 
characteristic feature of this class is that they have an oxygen functionality at C13.  They 
were first isolated from the South American V. glauca (Padolina et al., 1974), from where 
they get their name, and are ubiquitous in Vernonia species.  
 
The glaucolide constitutes the second largest number (87) of sesquiterpenoids reported from 
Vernonia and are made up of five skeletal types: glaucolides, prevernocisifolides, 
melampolides, stilpnomentolides and vernozanzibarolide (Figure 2.7 to Figure 2.24). The 
C8 ester substitution includes the acetate tiglate, methacrylate, seneciolylate, angilate, epoxy 
angilate and isobutanoylate among others.  The occurrence of epoxy and methylene groups in 
the ring results in reactive sites, and as such, glaucolides can undergo stereospecific 
transformations leading to many derivatives by in vivo reactions involving oxidation, 
hydrogenation, hydration, dehydrogenation and dehydration, among others (Fischer, 1990). 
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Figure 2.7  Glaucolide A type sesquiterpenoids 
 





22 Glaucolide A OCOCH3  CH3 O
 
C23H28O10 464 
23 8-Desacylglaucolide A-senecioate OCOCH3 CH3 O  C24H30O10 478 
24 8-Desacylglaucolide A-angelate OCOCH3  CH3 O
 
C24H30O10 478 
25 8-Desacylglaucolide A-tiglate OCOCH3 CH3 O
 
C24H30O10 478 




27 Glaucolide B OCOCH3 CH3 O  C21H26O10 438 
28 Glaucolide B-8-O-tiglate OCOCH3 CH3 O
 
C24H30O10 478 
29 Glaucolide B-propionate OCOCH3 CH3 -
COCH2CH3 
C22H28O10 452 
30 Glaucolide J OCOCH3 CH3 O
 
C23H30O10 464 




32 Stilpnotomentolide-8-O-angelate H CH3 
O
 C22H28O8 420 





34 Glaucolide-8-O-methacrylate CH3 H O
 
C22H26O8 418 
35 Glaucolide -8-O- senecioate CH3 H O  C22H28O8 420 
36 Vernofultan A CH3 H O  C19H24O8 380 














38 Confertolide OCOCH3  H O  
O
 C21H28O9 424 
39 Glaucolide K H OCOCH3 O
 
O
 C23H30O9 450 
40 Glaucolide L H OCOCH3 O
 





Figure 2.9  Glaucolide-D type sesquiterpenoids 
 





41 Glaucolide D H OCOCH3 O
O 
C23H28O10 464 























Figure 2.10  Glaucolide M type sesquiterpenoids 
 

























- C21H26O8 406 






- C22H28O8 420 
 
 
The formation of marginatin methyl ester (57) was proposed from biogenetic relations, in 
which acid catalyzed dehydration of 13-deacetyldehydromarginatin (55) results in C6/C7 
double bond and a free C13 methylene group. The methanol mediated ring opening of the γ-
lactone, allows for ketonization of C6 and subsequent elimination of the C8 side ester, thus 
forming the methyl ester (57) (Figure 2.11) (Jakupovic et al., 1986). 
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Figure 2.11  Biosynthetic transformation of 13-deacetyldehydromarginatin (55) to 




Figure 2.12  Marginatin type sesquiterpenoids 
 








 C22H28O7 404 
53 8-desacylmarginatin methacrylate O
 
O
 C21H26O7 390 
54 13-deacetylmarginatin O
 
H C20H26O6 362 
55 13-deacetyldehydromarginatin O
 




 C22H28O8 420.18 




Figure 2.13  Vernonataloide-type 
 





58 Vernonataloide βCH3 O
 
O
 C21H26O8 406 
59 17, 18-epoxyvernonataloide βCH3 O
O 
O
 C21H26O9 422 
60 8-desacylvernonataloide 
senecioate 
βCH3 O  
O





H C20H26O7 378 
62 8-desacylvernonataloide tiglate αCH3 O
 
O





CH3* C20H28O6 364 
64 ∆2, Vernonataloide methacrylate CH2OH O
 
O
 C21H24O9 420 
65 ∆2,Vernonataloide methyl butyrate CH2OH O
 
O
 C22H28O9 436 
66 4, 13-dihydroxy vernonataloide βCH3 O
 
H C19H22O8 378 
67 4-hydroxy vernonataloide βCH3 O
 
O
 C21H24O9 420 
 
*OR3 = CH3 (this compound is not oxygenated at this position) 
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68 prevernocistifolide A OH O
 
C22H26O9 434 
69 prevernocistifolide B OH O
 
C20H23O8 391 
70 2α,3α-epoxy prevernocistifolide A OH O
 
C22H26O10 450 
71 prevernocistifolide C OCOCH3 O
 
C22H25O9 476 




73 prevernocistifolide E OH O
 
C21H23O8 389 
74 prevernocistifolide F OH O
 
C22H23O8 403 
75 prevernocistifolide G OCOCH3 O
 
C22H23O9 431 






Figure 2.15  Melampolides-type 
 


















 C23H28O12 496 





80 Eremantholide A CH3 -C=CH-CH3
CH3  
C20H25O7 377 
81 Eremantholide B CH3 -CHCH2CH3
CH3  
C20H27O7 379 






       
* stereochemistry not indicated in the literature 
Figure 2.16  Keto-glaucolides 
 
No. Common name Mol. formula Mol. mass (g/mol) 
83 Glaucolide-1,3-diketone C24H28O11 492 
84 Glaucolide erinacolide C24H26O10 474 
85 Fasciculide-B C24H30O10 478 
 
 
* stereochemistry not indicated in the literature 
Figure 2.17  Natalensolide type 
 








87 Natalensolide C21H25O7 389 




Figure 2.18  Stilpnotomentolide skeletal type 
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Figure 2.19  Glaucogalamensolide type I sesquiterpenoids 
 
 



























98 bis epoxygermacranolide CHO O  C22H23O9 431 
 
 
Figure 2.20  Glaucogalamensolide type II sesquiterpenoids 
 




99 2, 3-epoxy-glaucogalamensolide C22H26O9 434 
100 2-acetoxy- glaucogalamensolide C24H30O10 478 
101 vernocinerolide C21H24O9 420 
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Figure 2.21  Ketovernocinerolide and poskeanolide 
 
No. Common name Mol. formula Mol. mass 
(g/mol) 
102 Ketovernocinerolide C21H28O8 408 




Figure 2.22  Germacranolides dilactone 
 





104 16,17-dihydrobrachycalyxolide  O
OH 
C25H32O11 508 










The transformation of brachycalyxolide (105) to the corresponding 16E-isobrachycalyxolide 
(107) is thought to proceed through an acid catalyzed reaction (Figure 23). The ring opening 
of the epoxide in (105) is followed by deprotonation at C6 and subsequent attack of the 
41 
hydroxyl group at C1 on C7, leading to the formation of a 1,7-oxygen bridge. This concerted 
reaction results in the elimination of the acetate group at C13 forming a free methylene 
system (Zdero et al., 1991).   
 
 




Figure 2.24  Vernozanzibarolide sesquiterpenoids 
 
No. Common name Mol. formula Mol. mass 
(g/mol) 
108 vernozanzibarolide C24H28O10 476 
109 isovernozanzibarolide C25H18O10 478 
2.3.3 Hirsutinolides 
Hirsutinolides are derived from the glaucolides and are represented from Figure 2.26 to 
Figure 2.34. The trivial name “hirsutinolides” was first given by Bohlmann and co-workers 
in 1978 when they discovered an unusual sesquiterpene lactone from Vernonia hirsuta with 
an endocyclic double bond and an oxygen at C13 (Bohlmann et al., 1978). Hirsutinolides 
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occur with a (Z,Z)-germacrane conformation and a diverse functionalized ester side chain 
such as the acetate tiglate, methacrylate, seneciolylate, angilate, epoxy angilate and 
isobutanoylate. They represent the largest number of sesquiterpenoids (91) reported from 
Vernonia.  
 
Hirsutinolides are made up of five skeletal types: Vernolides (110-140), keto-hirsutinolides 
(141-150), piptocarphin (151-186), iso-hirsutinolides (187-195) and 1-desoxy hirsutinolides 
(196-201). Although their structural and substitution patterns are similar, they have a diverse 
range of compounds. Hirsutinolides are related to the glaucolides by their chemical and 
conformational characteristics. Biogenetic relationships indicate that germacranolides are the 
primary precursors to hirsutinolides. The vernolide type hirsutinolides (110-140) are probably 
formed through the diepoxide (58) involving oxidation, hydration and dehydration leading to 
the hirsutinolides (Figure 2.25) (Bohlmann et al., 1978). 
 
 




Figure 2.26  Vernolide A and B type sesquiterpenoids  
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Figure 2.27  Vernolide C and D type sesquiterpenoids 
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Figure 2.28  More vernolide sesquiterpenoids including E and F types 
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Figure 2.29  Keto hirsutinolides 
 


































































Figure 2.30  Piptocarphin A-type  
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Figure 2.31  Piptocarphin C-type  
 
















































































































































* Note the change in configuration at C-8; ** Note the change in configuration at C-1. 
 
The formation of isohirsutinolides (187-195) was also thought to proceed through the 
costunolide (1), which undergoes epoxidation and subsequent isomerization, followed by 
further oxidation and hydrolysis. This provides the intermediate for a 1,4-O-bridge 
cyclization to the isohirsutinolides (Figure 2.32). Other hirsutinolides are presumably formed 
by a similar biogenetic pathway, often involving oxidation, hydrolysis, acetylation and 




Figure 2.32  Biosynthetic transformation showing the formation of isohirsutinolides 
(Bohlmann et al., 1978) 
 
Although the hirsutinolides are reported as naturally occurring plant compounds, there has 
been some controversy surrounding this finding, since several authors argue that they are 
artefacts of isolation during column chromatography. Tully et al. (1987) demonstrated that 
glaucolides undergo transformation under acidic conditions in silica gel resulting in the 
formation of hirsutinolides.  However, Pillay et al. (2007) argued that hirsutinolides are 
natural plant compounds because of their characteristic properties on TLC prior to column 
chromatography, justifying them as natural products.  
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Figure 2.33  Isohirsutinolide sesquitepenoids  
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Figure 2.34  1-desoxy hirsutinolide sesquiterpenoids  
 






































CHO C22H30O9 438 
2.3.4 Cardinanolides 
These are sesquiterpene lactones derived from the parent cardinane with a C6/C7 lactone ring 
and are represented from Figure 2.38 to Figure 2.40. There are seventeen (17) 
cardinanolides reported in Vernonia.  Their stereochemistry and position of the lactone ring is 
unique amongst the sesquiterpenoids. The C8 side chain substitution in all cardinanolides is 
limited to tiglate and methacrylate esters. Cardinanolides are represented by the 
vernojalcanolides (202-211) and vernomargolides (212-218).  
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The biosynthesis of the cardinane lactones involve cyclization of the (E,Z)-farnesyl cation 
resulting in a cis-germacryl cation which subsequently produced the cardinane skeleton after 
a 1,3-hydride shift (Figure 2.35) (Awouafack et al.,  2013). 
 
Figure 2.35  Biosynthetic transformation of E,Z-farnesyl cation to the cardinolides 
(Awouafack et al., 2013) 
 
Biogenetic relationships suggest that glaucolide-A is a precursor for cardinanolide 
transformation. However, Martínez-Vàzquez et al. (1986, 1992) demonstrated that 
glaucolide-A underwent rearrangement to the Vernojalcanolides in the presence of methanol 
and silica gel (Figure 2.36) and trans annular cyclization with boron trifluoride (BF3) to 
vernomargolides (Figure 2.37) through a nucleophillic attack of C2 on C7 with the loss of 
the C-13 acetoxy group (Rodriguez-Hahn et al., 1988).  This led to the belief that 
cardinanolides are artefacts of isolation and hence should not be regarded as biomarkers. 
 
 
Figure 2.36  Transformation of glaucolide A to the Vernojalcanolide-type sesquiterpene 
lactones (Martínez-Vàzquez et al., 1986) 
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Figure 2.37  Trans annular cyclization of glaucolide-A with boron trifluoride (BF3) resulting 




Figure 2.38  Vernopinguisolide type sesquiterpenoids 
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Figure 2.39  Vernojalcanolide-type sesquiterpenoids 
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Figure 2.40  Vernomargolide type sesquiterpenoids 
 






 C17H20O8 352 







 C19H24O8 380 














2.4 Elemanolides  
These are derived from the parent elemane and characterised by one or more γ- lactones at 
either the C6/C7 or C7/C8 positions (Figure 2.41 to Figure 2.47). A total of nineteen (19) 
elemanolides representing the different but related structural moieties have been reported 
from Vernonia species. The vernodalol skeletal type (219-223) is a non-lactonized elemane 
with C6-hydroxy and ester or carboxyl groups attached to C-11.  It is presumably a precursor 
for the synthesis of vernolepin type elemanolides (224-233) or products of biogenetic 
transformation in which the lactone moiety has been oxidized probably by enzyme activity. 
However, germacranolides such as onopordopicrin (6) is a likely precursor of vernolepin 
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biosynthesis (Figure 2.43). This is based on the biogenetic assumptions that germacranolides 
undergo cope-rearrangement reactions leading to elemanolides (Barrero et al., 1995).   
 
Figure 2.41  Vernodalol type sesquiterpenoids 
 
No. Common name R1 R2 Mol.- formula 
Mol. mass 
(g/mol) 
219 Vernodalol OH CH3 C20H25O8 393 
220 Vernodalinol OH H C19H23O8 379 
221 3'-deoxyvernadalol H CH3 C20H25O7 377 
222 Epivernodalol (2β) OH CH3 C20H25O8 393 




Figure 2.42  Vernolepin type sesquiterpenoids 
 





















































Figure 2.43  Biosynthesis of vernolepin type sesquiterpenoids (224-233) 
 
The elemanolide dimmers A (234) and B (235) were thought to have emerged through Diels-
Alder reactions involving vernodalin (232) and vernadalol (219), respectively (Figure 2.45). 
The synthesis of Vernodalidimer A involved the cycloaddition reaction of the enone moiety 
of one vernodalin with the methylene group of the other in a region-specific pattern (Liu et 
al., 2010).  It was observed that vernodalol (219-223) and vernolepin sesquiterpenoids (224-




Figure 2.44  Vernodalidimers 
 
No. Common name Mol. formula Mol. mass (g/mol) 
234 Vernodalidimers A C38H40O14 720 




Figure 2.45  Biosynthesis of Vernodalidimer A (234) 
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Vernomenin (236) is a rare skeletal type within Vernonia, representing the only elemanolides 
with a C7/C8 lactonized system. Vernomelitensin (238) represents an elemanolide with a 
C2/C3-diene as the only skeletal type in the Vernonia.  Plausible biogenetic relations (Zhang 
et al., 2014) showed that Vernomelitensin type formation is mediated by an acid catalyzed 
reaction of 11,13-dihydrovernolepin (226) followed by dehydration and reduction (Figure 
2.47). 
 
Figure 2.46  Melitensin type sesquiterpenoids  
 
No. Common name Mol. formula Mol. mass 
(g/mol) 
236 Vernomenin C15H17O5 277 
237 Melitensin C15H22O4 266 
238 Vernomelitensin C19H22O6 346 
 
 
Figure 2.47  Biosynthesis of Vernomelitensin type sesquitepenoids 
 
2.5 Eudesmanolides 
These are derived from the parent eudesmanes and characterised by cyclodecane skeleton 
with either C6/C7 or C7/C8 lactonized systems (Figure 2.49 and Figure 2.50), however only 
those with a C6/C7 lactone have been reported from Vernonia. These compounds are rarely 
61 
found in the genus Vernonia with only seven that have been previously reported, four of 
which (blumeoidolides A, B, C and D) were present in Vernonia blumeoides growing in 
Nigeria (Aliyu et al., 2015). The blumeoidolides have a characteristic 2-hydroxy-2-methyl 
butanoyl group at C8.  The hydroxy group of this moiety is acetylated in blumeoidolide B. 
This moiety presumably arises through oxidation of tiglate double bonds, followed by ring 
opening (Figure 2.48) (Aliyu et al., 2015).  
 
 




Figure 2.49  Eudesmanolide sesquiterpenes 
 
 
No. Common name Mol. formula Mol. mass (g/mol) 
239 reynosin C15H20O3 248 
240 5,6-epoxyeudesmanolide C15H18O5 278 




Figure 2.50  Blumeoidolide type  
 





242 Blumeoidolide A OCOCH3 OH C24H32O9 464 
243 Blumeoidolide B OH OCOCH3 C24H32O9 464 
244 Blumeoidolide C OH OH C22H30O8 422 
245 Blumeoidolide D - - C22H28O9 436 
 
The four blumeoidolides A (242), B (243), C (244) and D (245) have common eudesmane 
skeletal types and may have similar biogenetic relationships. Biomimetic transformations 
have indicated germacranolides as primary precursors of eudesmanolides (Fischer, 1990). 
Costunolide (1) is a common precursor in eudesmanolide biosynthesis. The formation of 
reynosin (239) is thought to occur by acid catalyzed epoxidation, followed by opening of the 
epoxide ring and cyclisation.  The olefinic methylene proton arises by loss of the proton at C-
15 (Figure 2.51). 
 
Figure 2.51  Biosynthesis of eudesmanolide: reynosin 
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2.6 Guaianolides 
Guaianolides are sesquiterpenoids of the bicyclic guanine origin. They are chemically bicyclo 
[5.3.0] decane compounds with a C-5 lactone ring (Miklos, 2012). Guaianolides generally 
occur as C-6/C-12 or C-8/C-12 lactonized systems (Figure 2.52 to Figure 2.61) 
predominantly within the Asteraceae, although many have also been isolated from the 
Apiaceae (Drew et al., 2009). There are 51 guaianolides reported to have been isolated from 
Vernonia species. Hydroxy groups, esterified hydroxy groups and epoxy groups are common 
substituents in guaianolides (Simonsen et al., 2013).  The guaianolides in Vernonia are broad 
with interesting chemical diversity.  They were largely isolated from South American species 
with very few reports from species of African and Asian origins.  
 
Zaluzanine guaianolides have a ketone functionality at C-3, with mostly an olefinic 
methylene at C-4 and C-12, however C-12 is reduced in 250 and 251 and C-4 is reduced in 
251 only.  Hydroxy or hydroxy derivatives occur at C-8 and C-9. 
 
 
Figure 2.52  Guaianolide type sesquiterpenoids with a ketone at C-3 
 





246 Hydrozaluzanine H OH C15H16O4 260 
247 Dehydrozaluzanin C OH OH C15H16O5 276 





OH C20H22O6 358 
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249  Zaluzanine H H C15H16O3 244 
250  8α-Hydroxy-11β, 13-
dihydro Zaluzanin C 
OH OH C15H18O5 278 
251 
 
3-oxograndolide H OH C15H18O4 262 
 
In 252-264, the C-3 ketone is reduced to a hydroxy group.  The substitution at C-4, C-8, C-9 
and C-12 is much like those of 246-251 above. 
 
 
Figure 2.53  Guaianolide type sesquiterpenoids with a hydroxy group at C-3 
 





252  Zaluzanin C H H C15H18O3 246 





H C19H22O6 346 
254  8α-hydroxy Zaluzanin C OH H C15H18O4 262 
255  8-O-acetyloyoxy Zaluzanin C O
O  
H C17H20O5 304 




H C19H22O5 330 
257  8-O-angeloyloxy Zaluzanin C 
O
O  
H C20H24O5 344 






H C20H24O5 344 
259  8-O-[2-(1-hydroxyethyl) 

























260  8-O-[2-(1-acetoxy ethyl) 





H C22H26O7 402 
261  8-O-(4'-hydroxy 
methacryloyoxy) Zaluzanin C 
O
OHO  
H C19H22O6 346 
262  3β-hydroxy-4, 15 
dehydrograndolide 
H OH C15H20O4 264 
263  3β-hydroxy grandolide H OH C15H22O4 266 
264  Tetrahydrozaluzanin C OH H C15H22O4 266 
 
Compounds 265-270 all have an acetyl group at C-3, with olefinic methylene groups at C-4 
and C-12 and no substituent at C-9.  C-8 contains esterified groups with the exception of 265. 
 
Figure 2.54  Guaianolide type sesquiterpenoids with an O-acetyl group at C-3 
 





265  Zaluzanin D H C17H20O4 288 
266  8-O-acetyloyoxy Zaluzanin D O
O  
C19H22O6 346 













270  8-O-(4'-acetoxy 






Compounds 271-275 have either esterified or glycosylated groups at C-3.  Compound 274 
has a hydroxy group at C-8, while 276 has an epoxy group at C-2 and C-3.  All these 
compounds have olefinic methylene groups at C-4 and C-12 and no substituents at C-9. 
 
Figure 2.55  Guaianolide type sesquiterpenoids with other oxygenated groups at C-3 





271  Zaluzanin A-3β-
O-senecioate 
OCOCH=C(CH3)2 H C20H24O4 328 
272  Zaluzanin A 
isobutyrate 
OCOCH(CH3)2 H C19H24O4 316 






H C21H28O8 408 

























H C30H34O11 570 
276 2,3-α-epoxy 
Zaluzanin 
- - C15H16O3 244 
 
 
The dehydrocostus lactones (277-282) have no functional group at C-3 or C-9.  In general, C-
4 and C-12 have olefinic methylene groups, however 281-282 has a hydroxymethyl group at 




Figure 2.56  Guaianolide type sesquiterpenoids with a fully reduced C-3 












dehydrocostus lactone  
OH C15H18O3 246 
280 8α-acetoxy 
dehydrocostus lactone 
OCOCH3 C17H20O4 288 
281 8α,15-dihydroxy 
dehydrocostus lactone 




- C15H22O4 266 
 
Jalcaguaianolide type sesquiterpenes have a guanianolide framework with a fully reduced C-
3, an epoxy group at C-4 and C-5 or a hydroxyl at C-4 and oxidized groups at C-8 and C-13. 
Compounds 283-287 with the epoxide contain hydroxyl and β-methyl groups at C-10, 
whereas in 288 an olefinic methylene group is present at C-10. 
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Figure 2.57  Jalcaguaianolide type sesquiterpenes 
 




283 Jalcaguaianolide B O
 
H C20H26O7 378 
284 13-Methoxyjalcaguaianolide B O
 
CH3 C21H28O7 392 
285 13-Acetoxyjalcaguaianolide B  O
 
O










 C19H24O8 380 
288 Jalcaguaianolide A - - C22H28O7 404 
 
The biosynthesis of jalcaguaianolide type sesquiterpenoids of the guaianolide type involves 
C-4 epoxidation of costunolide, ring closure forming bicyclo [5.3.0] decane compounds, then 
loss of a proton, forming the olefinic methylene at C-10 (Figure 2.58) (Fischer, 1990). 
 
 
Figure 2.58  Biosynthesis of guaianolides 
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Guaianolides might also be formed by the Cope rearrangement of elemanolide precursors 
under UV radiation (Zhang et al., 2014).  Dehydrogenation at C-10(14), followed by C-
11(13) leads to the guaianolides (Figure 2.59).  
 
 
Figure 2.59  Biosynthesis of guaianolides (283-288) 
 
In the vernocinolide guaianolide sesquiterpenoids 289-294, C-4, C-8 and C-10 is oxidised 
with hydroxy, methoxy or other oxygenated alkyl groups.  Vernocinolide and vernobockolide 
A contain a hydroxy group at C-6 and an oxygenation group at C-13.  Compound 292 is the 
most basic of these sesquiterpenoids, which is not oxygenated at C-6 or C-13.  Compounds 




Figure 2.60  Vernocinolide type guaianolide sesquiterpenoids  
 





289 Vernocinolide - - - - C21H31O9Cl 462 
290 Vernobockolide A OH O
 


















- - - - C18H24O6 336 
 
The eremanthine type sesquiterpenes have olefinic methylene groups at C-4 and C-11 and in 
some cases a substituent at C-8.  In 295-296 a double bond occurs at C-9(10) and in 297, 
epoxidation at the same position occurs.  In 298, a double bond is present at C-1(10), with an 





Figure 2.61  Eremanthine type sesquiterpenoids 
 



















 C20H24O6 360 
 
2.7 Miscellaneous types 
Miscellaneous sesquiterpene lactones are defined based on unique characteristics and have 
structural features or unusual substitutional patterns that is rare in the literature. In Vernonia, 
three different classes of compounds are classified as miscellaneous: (i) Vernonallenes (ii) 
Bourbonenolides and (iii) Potamopholide.  
 
Vernonallenes: These are bicyclic germacranolides bearing endocyclic allenes (Figure 2.62) 
(Bohlmann et al. 1981; 1982; Jakupovic et al., 1986). Basically, allenes are polyenes having 
cumulated dienes, characterized by a central carbon (sp-hybridized) sharing a double bond 
with two adjacent sp2 hybridized carbons (Luche et al., 1980). The vernonallenes (299-303) 
are characterized by a similar skeletal type with varying degrees of substitution such as 
epoxidation and hydroxylation.  No other allenes have been reported from Vernonia.  
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Figure 2.62  Vernonallene type sesquiterpenoids 
 




299 Vernoallenolide O  
O
 C19H22O6 346 
300 Vernoallenolide diol H H C15H18O4 262 
301 Vernoallenolide 
acetate 
H O  C17H20O5 304 
302 4,5-epoxyvernoallene - - C19H22O7 362 
303 4-hydroxyvernoallene - - C19H22O7 362 
 
Bourbonenolides (Figure 2.63) are characterised by a unique system with two cyclopentyl 
rings joined by a central cyclobutane ring in which a lactone moiety at C6/C7 is formed. 
Biogenetic relationships indicated that the glaucolides such as marginatin (52) are the 
precursor for bourbonenolide biosynthesis (Bohlmann et al., 1981).  This involves marginatin 
transformations through acid catalyzed ring opening of the epoxide, intramolecular 
cyclization of C10/C6, forming the first cyclopentyl ring. Attack on the C4 methylene system 
by a water molecule results in cyclization through the C1 carbocation to form the second 
cyclopentyl ring and the central cyclobutane ring (Figure 2.64).  
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Figure 2.63  Bourbonenolide type sesquiterpenoids 
 





























Figure 2.64  Biosynthetic transformation of bourbonenolides (304-308) 
 
Potamopholide: This is a germacranolide containing 3,8-O-bridged 10 membered hemi-
acetal skeleton (309) (Figure 2.65). It is structurally related to the 1,4-O-bridged compounds 
such as the hirsutinolides. The compound was thought to originate from an 8-O-acyl 
precursor such as the trans epoxide in the 1,3-diketone glaucolide (Figure 2.66). The 
abstraction of proton from C6 leads to a stable aromatic furan enolate anion.  Movement of 
electrons from the enolate anion, ultimately ending in ring opening of the epoxide with an 
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attack on the carbonyl group at C-1 results in a 1,4-O-bridge similar to the hirsutinolide type.  
Ring opening of this furan ring and cyclisation of the oxygen at C-8 with the carbonyl group 
at C-3 leads to the potamopholide (309). The compound was isolated from V. potamophila 




Figure 2.65  The structure of potamopholide 
 
No. Common name Mol formula Mol mass 
(g/mol) 




Figure 2.66  Plausible biosynthesis of potamopholide (309) 
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2.8 Conclusion 
The sesquiterpene lactones have been studied for four decades with numerous reports on the 
isolation and structure elucidation of various derivatives. The analysis of phytochemical data 
on the sesquiterpenoids based on structural variation is intended to provide a holistic picture 
of these compounds in relation to the number of derivatives that have been isolated from each 
class. A total of 309 sesquiterpene lactones were reported from 81 Vernonia species. The 
germacranolides represent the largest class with 219 (71%), guaianolides 53 (17%), 
elemanolides 10 (6%), eudesmanolides 7 (3%) and miscellaneous 10 (3%) as shown in 
Figure 2.67.  
 
 
Figure 2.67  Distribution of major sesquiterpene lactones in Vernonia 
 
The germacranolides constitutes four subgroups each with structural or chemical features of 
considerable importance. The non-glaucolides and cardinanolides are poorly represented 
within the germacranolides with twenty one and five structural motifs representing 7% and 
6%, respectively of sesquiterpenoids from Vernonia.  However, the glaucolides are a highly 
diverse sub-group of the germacranolides containing thirty one chemical motifs (Figure 2.7 
through to Figure 2.24) representing 28% of sesquiterpene lactones of the Vernonia genus. 
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One of the common features in the glaucolides is the consistent substitution pattern at C-1 
and C-13. 
 
The hirsutinolides are another class of germacranolides with interesting chemical diversity. 
They represents 30% of the 309 sesquiterpene lactones from Vernonia (Figure 2.68), the 
largest proportion, marginally over the glaucolides at 28%. There are five structural motifs of 
hirsutinolides based on their different substitution patterns (Figure 2.26 to Figure 2.34). An 
important re-occuring feature in  the hirsutinolides is hydroxylation at C-1. The vernolide C 




Figure 2.68  Distribution of sesquiterpene lactone skeletal types in Vernonia 
 
The guaianolides are represented by only fifty seven compounds from twenty one structural 
motifs which constitute 17% of sesquiterpene lactones from Vernonia (Figure 2.68). It was 
observed that the most representative guaianolide-type sesquiterpenoids are those with a 
hydroxy group at C-3. The elemanolides (6%), eudesmanolides (2%) and miscellaneous 
sesquiterpenoids (3%) are represented by poor occurrence in Vernonia. However, it is 
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apparrent that sesquiterpene lactones are diverse in their chemical classification and structural 
derivatives within Vernonia. 
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CHAPTER 3 SESQUITERPENE LACTONES FROM THE AERIAL 
PARTS OF VERNONIA BLUMEOIDES GROWING IN NIGERIA 
 
Abstract 
Four eudesmanolide sesquiterpene lactones (1-4) were isolated from the aerial parts of 
Vernonia blumeoides used in Nigerian ethnomedicine for the treatment of diarrhoea and 
malaria.  Compound 1 demonstrated limited but interesting antibacterial activity against 
Bacillus, Staphylococcus and Streptococcus species.  The crystal structure of compound 1 
allowed the absolute configuration of the stereocentres in the molecule to be assigned. 
 
 





Vernonia blumeoides Hook f. (Asteraceae) is a perennial herb growing in grasslands or 
abandoned fields across Northern Nigeria (Hutchinson and Dalziel, 1963).  It is an erect 
shrub of 2-4 feet high with leaves shortly attached to the stems.  In full bloom, the flower 
heads are reddish to purple in colour. The plant is known as “Bagashi” in Hausa language and 
commonly used in Northern Nigerian traditional medicine for the treatment of diarrhoea and 
malaria (Aliyu et al., 2011; Ibrahim et al., 2011).  Plants of the genus Vernonia are widely 
used as vegetables and as medicinal herbs in African traditional medicine for the treatment of 
quite a number of ailments including gastrointestinal disorders, dysentery, malaria, skin 
diseases, fever, hepatitis, venereal diseases, diabetes and as an anthelmintic, amongst others 
(Akinpelu, 1999; Cioffi et al., 2004; Nergard et al., 2004; Tchinda et al., 2002).  
Phytochemical investigations of Vernonia species have resulted in the isolation of 
triterpenoids (Kiplimo et al., 2011), steroidal glycosides (Cioffi et al., 2004; Liu et al., 2009; 
2010), flavonoids (Seetharaman and Petrus, 2004) and numerous classes of sesquiterpene 
lactones with interesting antibacterial (Rabe et al., 2002), anticancer (Williams et al., 2005; 
Buskuhl et al., 2010; Luo et al., 2011; Liao et al., 2012), antiplasmodial (Pillay et al., 2007) 
and anti-inflammatory activities (Youn et al., 2012).  The sesquiterpene lactones are known 
to serve as chemotaxonomic markers for the genus Vernonia. 
 
Although several other Vernonia species have been studied, especially from Africa and South 
America where the genus Vernonia was thought to have originated (Harborne and Williams, 
1977), no previous phytochemical studies have been carried out on Vernonia blumeoides.  
Herein, we report on the isolation and characterisation of novel sesquiterpene lactones of the 
eudesmanolide class from the aerial part of the plant and its antibacterial activity. 
 
88 
3.2 Results and Discussion 
Chemistry 
Eudesmanolides have rarely been found in most African Vernonia species. In this study, the 
aerial parts of Vernonia blumeoides yielded four novel eudesmanolides (1-4), in addition to 
the known compounds, chrysin (5), apigenin (6) (Wawer and Zielinska, 2001), luteolin (7) 
(Li et al., 2008), stigmasterol (8) (Forgo and Kövér, 2004) and lupeol (9) (Laghari et al., 
2011).  
Compound 1 (Figure 3.1) was isolated as a white crystalline solid with a molecular formula 
of C24H32O9 established by the quasi-molecular ion peak at m/z 487.1938 [M+Na]+ (calcd. for 
C24H32O9Na, 487.1944) in the HREIMS.  In the IR spectrum, absorption bands of the 
hydroxyl (3530 cm-1) and the ester carbonyl (1782 and 1736 cm-1) were observed.   
 
The 1H and 13C NMR data (Table 3.1) showed resonances typical of an eudesmane 
sesquiterpene skeleton similar to 1α,8α-dihydroxy-5αH,10α-eudesma-3,11(13)-dien-6-olide 
(10) (Triana et al., 2013), with characteristic oxygenated methine resonances at δΗ 4.79 (1H, 
dd, J = 9.8, 6.8 Hz, H-1), 3.96 (1H, t, J = 13.4 Hz, H-6) and 5.22 (1H, td, J = 10.8, 4.5 Hz, H-
8), a doublet methine resonance at δΗ 2.48 (1H, J = 12.5 Hz, H-5), an olefinic resonance at δΗ 
5.32 (1H, br s, H-3), two exomethylene protons at δΗ 6.08 (1H, d, J = 2.8 Hz, H-13a) and 
5.43 (1H, d, J = 2.8 Hz, H-13b),  an aliphatic methyl resonance at δΗ 0.98 (3H, s, H-14) and 
an olefinic methyl resonance at δΗ 1.79 (3H, s, H-15).   
 
In addition to the resonances of the eudesmane skeleton, there were two additional methyl 
resonances at δH 1.33 (3H, s, H-19), 1.22 (3H, d, J = 6.2 Hz, H-20), an oxygenated methine 
resonance at δH 5.08 (1H, q, J = 6.2, H-18), two additional acetyl groups at C-18 and C-1 (δC 
169.2, 20.7 and 170.1, 20.9) and an additional tertiary carbon at δC 76.2 (C-17). An acetyl 
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group was assigned to C-1 since HMBC correlations from H-1 to C-23 (δC 170.1) and H-24 
to C-1 (δC 76.0) were observed (Figure 3.2).  An ester group was also assigned to C-8 
because of the observed HMBC correlations from H-8 to C-16 (δC 174.2).  The second acetyl 
group was assigned to C-18 due to HMBC correlations from H-18 to C-21 (δC 169.2).  This 
position was further occupied by the methyl group (C-20), accounting for the splitting pattern 
of H-18 being a quartet and H-20 being a doublet.   
 
The 2-methylbutanoyl group was established by HMBC correlations from H-18 to C-16 and 
from H-19 to C-17.  These correlations indicated that a 3-acetate-2-hydroxy-2-methyl 
butanoyl group was present at C-8.  This side chain could be considered an oxidized tigloyl 
group, possibly through epoxidation of the tigloyl double bond followed by ring opening of 
the epoxide with further acetylation of the hydroxy group. The absolute configuration of 1 
was determined by single crystal X-Ray diffraction analysis (Figure 3.3).  This was 
supported by selected NOESY interactions (Figure 3.4).  Compound 1 was thus identified as 
1β-acetyl-8α-(3-acetyl-2-hydroxy-2-methyl)butanoyl-5αH,10β-eudesma-3,11(13)-dien-
6α,12-olide and given the trivial name blumeoidolide-A.   
 
The molecular formula C24H32O9 of compound 2 was deduced from HREIMS, which showed 
a quasi-molecular ion peak at m/z 487.1935 [M+Na]+ (calcd. for C24H32O9Na, 487.1944).  
Comparison of the 1H and 13C NMR spectroscopic data with 1 (Table 3.1) showed that they 
were very similar, except for the chemical shift of H-1 at δH 3.62 (∆δH -1.17) and H-19 δH 
1.60 (∆δH +0.27) as well as C-16 at δC 168.4 (∆δC -5.8) and C-17 at δC 81.6 (∆δC +5.4).  This 
prompted us to assign the acetyl group to C-17 instead of C-1 to form a structural isomer of 
1.  The NOESY interactions of H-8/H-6 and H-6/H-14 shown as β, and H-18/H-19 shown as 
α, indicate that the relative configuration of 2 is the same as that of 1.  We have thus 
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identified compound 2 as 8α-(2,3-diacetyl-2-methyl) butanoyl-1β-hydroxy-5αH,10β-
eudesma-3,11(13)-dien-6α,12-olide and given the trivial name blumeoidolide-B. 
 
Compound 3 was obtained as a yellow amorphous solid. Unfortunately, HREIMS or 
elemental analysis data could not be obtained due to insufficient quantity; however, an M+ - 
H2O peak was evident at m/z 404 in the EIMS spectrum.  The 1H and 13C NMR data was 
similar to both 1 and 2, the difference being the absence of a carbonyl and methyl resonance 
in the 13C NMR spectrum.  This indicated that compound 3 had one less acetyl group than 1 
and 2.  Since the NMR data of H-1 and C-1 was the same as that of 1, and H-16 and C-17 the 
same as that of 2, the only acetyl group was assigned to C-18. Both H-6 and H-8 showed 
NOESY interactions with H-14, indicating the same relative configuration to that of 1 and 2.  
Compound 3 was thus identified as the monoacetylated, 8α-(3-acetyl-2-hydroxy-2-methyl) 
butanoyl-1β-hydroxy-5αH,10β-eudesma-3,11(13)-dien-6α,12-olide, with the trivial name, 
blumeoidolide-C.   
 
Compound 4 was isolated as a yellowish gummy residue.  HREIMS and EIMS data could not 
be obtained for compound 4 due to insufficient quantity, however the TOF MS indicated an 
M+ -CH3COO- ion peak at m/z 378.  In the IR spectrum, absorption bands for hydroxyl (3434 
cm-1) and ester carbonyl (1734 cm-1) functional groups were observed.  The NMR spectra of 
compound 4 was acquired in deuterated DMSO and showed a similar pattern to the 
eudesmane sesquiterpene lactones with the two proton resonances for the methylene group 
(H-13a and H-13b) at δΗ 6.15 and 5.77 (each 1H, d, J = 2.9 Hz), the oxygenated methine 
groups, H-6 and H-8 at δΗ 5.28-5.33 (2H, m), H-1 at δH 3.69 (1H, dt, J = 13.1, 5.0 Hz) and 
two methyl groups on the eudesmane skeleton, H-15 at δH 1.90 and H-14 at δH 1.25.  The side 
chain 1H NMR resonances for the 3-acetyl-2-hydroxy-2-methyl butanoyl group was the same 
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as that of 1 and 3.  In comparison to compound 3, the two methine protons H-5 (δH 2.34) and 
H-3 (δH 5.33) were missing.  In the 13C NMR spectrum, an additional ketone resonance at δC 
197.4 was assigned to C-3 and the olefinic resonance at δC 152.2 was assigned to C-5.  
HMBC correlations were seen from both H-2 (δH 2.42 and 2.55) and H-15 to C-3 (δC 197.4) 
and from H-15, H-14 and H-9 to C-5 (δC 152.2).  Thus, the double bond in compound 4 
shifted from ∆3 to the ∆4 position with a ketone at C-3 resulting in an α,β-unsaturated ketone 
moiety.   
 
Figure 3.1  The structures of sesquiterpene lactones isolated from Vernonia blumeoides 
 
The relative configuration was determined by the NOESY interactions of H-6/H-1, H-8/H-1, 
H-6/H-14 and H-8/H-14 (β-orientation) and between H-19 and H-18 (α-orientation).  
Accordingly, compound 4 was identified as 8α-(3-acetyl-2-hydroxy-2-methyl) butanoyl-1α-
hydroxy-3-keto-10β-eudesma-4,11(13)-dien-6α,12-olide and given the trivial name 
blumeoidolide-D. 
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Table 3.1  1H and13C NMR data for compounds 1-3 (in CDCl3, 400 MHz) and 4 (in DMSO-
d6, 600 MHz) a, b 
 1  2  3  4  
No δH δC δH δC δH δC δH δC 
1 4.79 (dd, 9.8, 6.8)  76.0 
3.62 (dd, 
9.9, 6.6) 






2α *2.45 (m) 29.0 
*2.36 
(m) 32.5 
*2.29 (m) 32.8 2.55 (dd, 16.1, 13.1)  42.7 
2β 1.89 (m)  




3 5.32 (br, s) 121.4 5.34 (br, s) 
121.9 **5.33 (br, 
s) 
121.9 - 197.4 
4 - 132.0 - 132.4 - 132.4 - 127.9 








6 3.96 (t,13.4) 78.3 
4.00 (t, 
11.1) 
78.9 4.00 (t, 
11.0) 
78.8 # 5.28-5.33 
(m) 
78.2 
7 2.80 (tt, 10.9, 2.9) 53.1 
2.81 (tt, 
10.9, 2.8) 53.6 
2.81 (tt, 




8 5.22 (td, 10.8, 4.5) 70.7 
5.27 (td, 
10.8, 4.5) 70.9 
**5.28 (td, 





1.12 (br t, 
9.2) 39.9 
1.12 (br 
t, 9.2) *40.4 
1.11 (br t, 
11.9) 40.6 
1.25 (m) 43.8 
9β 
2.12 (dd, 
12.6, 4.5)  
2.41 (dd, 
12.7, 4.5) 
 *2.28 (dd, 
12.2, 4.6) 
 2.38 (dd, 
13.0, 4.5) 
 
10 - 38.9 - *40.4 - 40.3 - 43.2 
11 - 136.0 - 135.9 - 136.3 - 136.3 
12 - 169.0 - 169.8 - 169.4 - 168.8 







13b 5.43 (d, 2.8)  
5.87 (d,  
2.8) 
 5.45 (d, 
2.9) 
 5.77 (d, 
2.9) 
 
14 0.98 (s) 13.3 0.89 (s) 12.1 0.90 (s) 13.2 1.25 (s) 18.4 
15 1.79 (br, s) 22.9 
1.81 (br, 
s) 
23.2 1.81 (s) 23.1 1.90 (s) 11.0 
16 - 174.2 - 168.4 - 174.3 - 173.9 






72.4 5.11 (q, 
6.4) 
74.3 4.99 (d, 
6.2) 
73.1 
19 1.33 (s) 21.7 1.60 (s) 17.6 1.37 (s) 21.5 1.31 (s) 23.1 
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 1  2  3  4  
No δH δC δH δC δH δC δH δC 
         
20 1.22 (d, 6.2) 13.1 
1.23 (d, 
6.5) 
14.5 1.26 (d, 
6.4)  
12.2 1.18 (d, 
6.7) 
13.8 
21 - 169.2 - 170.0 - 170.4 - 170.0 
22 1.91 (s) 20.7 2.05 (s) 21.1 2.01 (s) 21.0 1.96 (s) 21.3 
23 - 170.1 - 170.0 - - - - 
24 1.98 (s) 20.9 2.07 (s) 21.1 - - - - 
aAssigned by DEPT, COSY, HMBC and HSQC experiments 
bChemical shifts are given in (ppm) relative to internal reference, tetramethylsilane (TMS). 
Coupling constants (J) are given in Hz  
#, * and ** indicate overlapping resonances 
 
 
Figure 3.2  Selected HMBC (HC) correlation for compound 1 
 
 
Figure 3.3  Ortep diagram for compound 1 
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Figure 3.4  Selected NOESY interactions for compound 4 
 
Antibacterial Activity 
In comparison to the standard antibiotics, lactone 1 showed moderate activity against Bacillus 
subtilis, the six Staphylococcus spp. strains and Streptococcus pyogenes (Table 3.2).  Similar 
antibacterial activity was seen with the crude hexane, dichloromethane and ethyl acetate 
extracts, although the crude extracts were not always active against all of the Staphylococcus 
spp. strains.  Lactone 2 showed moderate activity against Bacillus subtilis only, with an 
inhibition zone of 9 mm.  The MIC values of lactones 1 and 2 using a 2-fold serial broth 
microdilution assay were determined to be 2.15, 4.30 and 2.15 mM (lactone 1) and 4.30, 8.62 
and 2.15 mM (lactone 2) for S. aureus ATCC 29213, S. aureus ATCC 43300 and B. subtilis 
ATCC 6633, respectively.   The antibacterial activity of compound 1 against Gram-positive 
bacteria was also shown by Erasto et al. (2006) who isolated vernolide and vernodalol from 
the leaves of Vernonia amygdalina.   
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Table 3.2  Antibacterial activity of compounds 1, 2, Ampicillin, Tetracycline and crude 
extracts from V. blumeoides 
Zones of inhibition (mm)* 
Test organisms Ampicillin Tetracycline 1 2 Hex DCM EtOAc 
Bacillus subtilis 
ATCC 6633 





























35.5±0.01 27±0.00 14±0.01 0 7±0.01 0 10±0.012 
Mass of compounds on disk: 1 (2 mg), 2 (40 µg), Hex: (2 mg), DCM (2 mg), EtOAc (2 mg), 
Ampicillin (10 µg), Tetracycline (30 µg). Results expressed as mean±SD of three 
independent determinations. Hex: hexane, DCM: dichloromethane, EtOAc: ethyl acetate 
 
3.3 Experimental 
General experimental procedures 
All NMR data, 1H, 13C and 2D experiments were recorded on a Bruker AvanceIII 400 MHz 
spectrometer.  Samples were acquired with deuterated chloroform (CDCl3) or deuterated 
dimethyl sulfoxide (DMSO-d6). The spectra were referenced according to the 
deuteriochloroform signal at δH 7.24 (for 1H NMR spectra) and δC 77.0 (for 13C NMR 
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spectra) for CDCl3 and δH 2.50 and δC 39.51 for DMSO-d6. The HREIMS spectra were 
obtained from a Bruker Micro TOF-QII instrument.  IR spectra were recorded using a Perkin 
Elmer Universal ATR spectrometer. Optical rotations were measured at room temperature on 
a Perkin ElmerTM Model 341 Polarimeter with a 10-cm flow tube.  UV spectra were obtained 
on a Varian Cary UV-VIS Spectrophotometer. The melting points were determined on an 
Ernst Leitz Wetziar micro-hot stage melting point apparatus.  Merck silica gel 60 (0.040–
0.063 mm) was used for column chromatography and crude samples were separated on 3 cm 
diameter columns, while purifications were carried out on 2 cm diameter columns.  Merck 20 
cm x 20 cm silica gel 60 F254 aluminium sheets was used for thin-layer chromatography. The 
TLC plates were analysed under a UV lamp with wavelength 254 and 366 nm and sprayed 
with an anisaldehyde- concentrated sulfuric acid-methanol mixture (1:2:97). 
 
Plant material 
The plant was collected in August, 2010 along Giwa road in Samaru-Zaria, Kaduna state, 
Nigeria. It was authenticated by U.S. Gallah at the Herbarium unit of the Department of 
Biological Sciences, Ahmadu Bello University, Zaria, Nigeria where a voucher specimen 
(1784) was deposited. 
 
Extraction and isolation   
The dried aerial part (1700 g) was subjected to sequential extraction with hexane, 
dichloromethane (DCM), ethyl acetate (EtOAc) and methanol (MeOH) and all extracts were 
concentrated under reduced pressure on a rotary evaporator (Büchi® rotary evaporator R-200) 
to yield 12.50, 33.89, 19.25 and 28.70 g of extract, respectively. The hexane extract (10.09 g) 
was separated by column chromatography with a hexane: DCM gradient starting with 100% 
hexane and gradually increasing the polarity by 10% DCM every 500 mL until 100% DCM 
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was reached.  Fifty five fractions of 100 mL each were collected and combined into six 
fractions (A- fr. 1-12, B- fr. 13-20, C- fr. 21-29, D- fr 30-39, E- fr. 40-48 and F- fr. 49-55).  
Fraction C was purified with hexane: DCM (1:1) where fraction 6 yielded an amorphous 
white compound, stigmasterol (8) (53 mg).  Purification of fraction D with hexane: DCM 
(4:6) yielded a light yellowish compound in fractions 22-32.  Sub fraction D22-32 was further 
purified with the same solvent system to yield lupeol (9) (88 mg) in fraction 11.  
 
The DCM extract (15.45 g) was separated using a stepwise gradient of hexane: DCM: 
EtOAc: MeOH and collecting 100 mL fractions, which was further combined into 8 fractions; 
100% hexane (A- fr. 1-4), hexane: DCM (7:3) (B- fr. 5-8), 100% DCM (C- fr. 9-13), DCM: 
EtOAc (9:1) (D- fr. 14-17), DCM: EtOAc (8:2) (E- fr. 18-26), 100% EtOAc (F- fr. 27-31), 
EtOAc: MeOH (7:3) (G- fr. 32-34) and 100% MeOH (H- fr. 35-38). Fraction E was purified 
with hexane: EtOAc (7:3) collecting 50 mL fractions, where fractions 27-50 yielded 
compound 1 (780 mg), which was recrystallised with MeOH.  Fractions 55-60 yielded a 
brown amorphous compound 2, which was purified with hexane: EtOAc (6:4) to yield the 
pure compound in fractions 22-24 (10 mg).  
 
The EtOAc extract (8.04 g) was separated on a silica gel column and eluted with a hexane: 
EtOAc gradient (1:1, 4:6 and 3:7) collecting 100 mL fractions and further combined into 3 
fractions; A- fr. 1-12, B- fr. 13-22 and C- fr. 23-30. Fraction A was further purified (with 
hexane: EtOAc, 1:1) in which fr. 4-9 yielded a mixture of two compounds.  This mixture was 
purified with the same solvent system to yield 18 mg of chrysin 5 in fr. 5-8 and more of 
compound 1 in fractions 13-18 (32 mg recrystallized with MeOH).  Fraction B was purified 
with hexane: EtOAc (4:6) to give a yellowish residue in fr. 14-16, which was purified with 
hexane: EtOAc (1:1) to yield compound 3 (6.45 mg) in fr. 10-12.  Purification of C with 
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hexane: EtOAc (3:7) yielded compound 4, a yellowish gummy residue, which upon 
recrystallization from MeOH yielded 6.20 mg of the pure compound. The MeOH extract 
(15.86 g) was dissolved in distilled water (200 mL), filtered and partitioned with an equal 
amount of butanol. The butanol fraction (3.08 g) was subjected to column chromatography on 
Sephadex LH-20 (1.5 cm diameter column) using MeOH and collecting 10 mL fractions. 
Fractions 12-19 was further purified on a 2 cm diameter silica column using hexane: EtOAc 
(1:1) where fr. 1-4 afforded apigenin (6) (10 mg) and fr. 5-8 yielded luteolin (7) (15 mg).   
 
1β-acetyl-8α-(3-acetyl-2-hydroxy-2-methyl)butanoyl-5αH,10β-eudesma-3,11(13)-dien-
6α,12-olide (blumeoidolide-A) (1) white crystalline (780 mg); m.p.  128-129 °C; [α]D20 
+29.5° (c. 0.13 CHCl3); IR υmax (cm-1) 3530 (OH), 2990, 2952, 1782 (C=O), 1736 (C=O); 1H 
and 13C NMR (see Table 3.1); HREIMS m/z 487.1938 [M+ + Na] (calcd. for C24H32O9Na, 
487.1944). 
8α-(2,3-diacetyl-2-methyl)butanoyl-1β-hydroxy-5αH,10β-eudesma-3,11(13)-dien-6α,12-
olide (blumeoidolide-B) (2) a brown amorphous solid (10.05 mg); m.p. 84-85 °C; [α]D20  
+43.5º (c. 0.1 CHCl3); IR υmax (cm-1) 3483 (OH), 2952, 1744 (C=O), 1449; 1H and 13C NMR 
(see Table 3.1); HREIMS m/z 487.1935 [M+ + Na] (calcd. for C24H32O9Na, 487.1944).   
8α-(3-acetyl-2-hydroxy-2-methyl) butanoyl-1β-hydroxy-5αH,10β-eudesma-3,11(13)-dien-
6α,12-olide (blumeoidolide-C) (3) a yellowish amorphous solid (6.45 mg); m.p.  124-125 °C; 
[α]D20  +50.0º (c. 0.1  CHCl3);  IR υmax (cm-1) 3448 (OH), 2929, 1736 (C=O), 1458; 1H and 
13C NMR (see Table 3.1); EIMS (m/z) 404 (45) [M+ - H2O], 281 (45), 247 (65), 228 (100), 
201 (80), 147 (98). 
8α-(3-acetyl-2-hydroxy-2-methyl)butanoyl-1α-hydroxy-3-keto-10β-eudesma-4,11(13)-dien-
6α,12-olide (blumeoidolide-D) (4) a yellow gummy residue (6.20 mg); m.p. 108-109 ºC; 
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[α]D20 +35.0º (c. 0.1 CH3OH); IR υmax (cm-1) 3434 (OH), 2941, 1734 (C=O), 1736 (C=O); 1H 
and 13C NMR (see Table 3.1); TOF MS ES+ (m/z) 378 (80) [M+ - CH3COO], 357 (40), 301 
(65), 265 (100). 
 
Antimicrobial susceptibility testing 
Antimicrobial testing was done on crude extracts of Vernonia blumeoides and the pure 
lactones 1 and 2 against bacterial isolates (Table 3.2) using the disc diffusion method by 
standard procedures (CLSI, 2007).  Compounds 3 and 4 were isolated in small amounts and 
were not assayed as the samples decomposed before the assays could be carried out.  Crude 
extracts (DCM, hexane, EtOAc and MeOH) and lactone 1 were dissolved in DMSO to a final 
concentration of 50 mg mL-1. From the stock solutions, 40 µL (0.04 mL) were impregnated 
onto blank discs (0.04 mL x 50 mg mL-1) resulting in 20 mg of extract concentration 
absorbed. While for lactone 2, the final concentration prepared was 1 mg mL-1 (1 mg 
dissolved in 1 mL DMSO), from where 40 µL (0.04 ml) were also impregnated onto blank 
discs (6 mm; MAST, UK). The concentrations of compound 2 absorbed (0.04 mL x 1 mg 
mL-1) were 0.04 mg (40 µg). The difference in masses of compounds 1 and 2 was due to 
quantity of compounds isolated. Compound 1 was isolated up to 100 mg, while compound 2 
yielded only 10 mg which depleted after chemical characterization. In all cases, solutions on 
discs were allowed to dry.   Testing was done in duplicate and tetracycline (TE30; 30 µg disc 
potency) and ampicillin (AMP10, 10 µg disc potency) discs (Oxoid, UK) were used as 
standard antimicrobial agent controls in addition to DMSO-impregnated discs which served 
as the negative control.  Antibacterial activity was determined by measuring the diameter of 
the inhibition zone (clear zone) formed around the discs.  Criteria for assigning susceptibility 
or resistance to AMP10 was as follows: Sensitive (S) ≥ 17 mm, Intermediate (I) = 14 – 16 
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mm, Resistant (R) ≤ 13 mm, while those for TE30 were: (S) ≥ 19 mm, (I) 15 – 18 mm, (R) ≤ 
14 mm (CLSI, 2007).  
 
MIC determination using broth microdilution assays 
Staphylococcal isolates, S. aureus ATCC 29213 and ATCC 43300, and B. subtilis ATCC 
66333 were cultured overnight on TSA and resuspended in sterile distilled water equivalent 
to a 0.5 McFarland standard.  These were used to determine the minimum inhibitory 
concentrations using two-fold serial broth microdilution assays (Andrews, 2001).  Microtiter 
plate wells contained 90 µL per well of Mueller Hinton (MH) broth, 10 µL of cell suspension 
and lactones 1 and 2 at doubling dilution concentrations ranging from 0.5 - 32 mg mL-1.  
Tetracycline (20 mg mL-1; Sigma, Germany) was used as a reference antimicrobial agent 
against each bacterium.  Wells were inoculated in triplicate for each isolate at each of the 
specified concentrations and incubated at 37 °C without shaking.  The highest dilution 
(lowest concentration of lactone), showing no visible growth was regarded as the MIC 
(Andrews, 2001).  Negative controls contained MH broth only and growth controls contained 
MH broth and respective cell suspensions only. 
 
X-Ray crystallography 
A crystal of dimension of 0.25 x 0.28 x 0.48 mm3, was selected and glued on to the tip of a 
glass fibre. The crystal evaluation and data collection were performed on a Bruker Smart 
APEXII diffractometer with Mo Kα radiation (λ = 0.71073 Å).  The data collection method 
involved ω scans of width 0.5°.  Data reduction was carried out using the program SAINT+. 
The structure was solved by direct methods using SHELXS and refined. Non-H atoms were 
first refined isotropically and then by anisotropic refinement with full-matrix least-squares 
calculations based on F2 using SHELXS.  All H atoms were positioned geometrically and 
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allowed to ride on their respective parent atoms. All H atoms were refined isotropically.  The 
final least-squares refinement of 305 parameters against 4242 data resulted in residuals R 
(based on F2 for I ≥2σ) and wR (based on F2 for all data) of 0.0519 and 0.1285, respectively. 
The final difference Fourier map was featureless.   Crystal data: C24H32O9, MW = 464.50, 
orthorhombic, space group P212121, crystal cell parameter a = 6.2596(2) Å, b = 10.1164(3) 
Å, c = 38.2097(9) Å, V = 2419.61(12) Å3, Z = 4, Dcalc = 1.275 Mg/m3.  Crystallographic data 
(excluding structure factors) for the structure in this paper has been deposited with the 
Cambridge Crystallographic Data Centre, CCDC, 12 Union Road, Cambridge CB21EZ, UK.  
Copies of the data can be obtained free of charge on quoting the depository number CCDC-




Four sesquiterpene lactones, all with similar backbones were isolated from the aerial parts of 
V. blumeoides and their structures were elucidated using spectroscopic data and X-Ray 
crystallography.  Compounds 1 and 2 were assayed for their antibacterial activity, of which, 1 
showed antibacterial activity against Staphylococcus spp. strains and Bacillus subtilis.  The 
antibacterial activity displayed by 1 and the crude extracts of the aerial parts of the plant 
suggest a potential reason for the use of the plant in Northern Nigeria for the treatment of 
Gram-positive-associated skin infections.  
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CHAPTER 4  QUORUM SENSING INHIBITORY POTENTIAL AND 
MOLECULAR DOCKING STUDIES OF SESQUITERPENE 
LACTONES FROM VERNONIA BLUMEOIDES 
Abstract 
The increasing incidence of multidrug-resistant Gram-negative bacterial pathogens has 
focused research on the suppression of bacterial virulence via quorum sensing (QS) inhibition 
strategies, rather than the conventional antimicrobial approach.  The anti-virulence potential 
of sesquiterpene lactones previously isolated from Vernonia blumeoides was assessed by 
inhibition of quorum sensing and in silico molecular docking.  Inhibition of QS-controlled 
violacein production in Chromobacterium violaceum was quantified using violacein 
inhibition assays.  Qualitative modulation of QS activity and signal synthesis was 
investigated using agar diffusion double ring assays and C. violaceum and Agrobacterium 
tumefaciens biosensor systems.  Inhibition of violacein production was concentration-
dependent, with ≥90% inhibition being obtained with ≥2.4 mg mL-1 of crude extracts.  
Violacein inhibition was significant for the ethyl acetate extract with decreasing inhibition 
being observed with dichloromethane, hexane and methanol extracts.  Violacein inhibition 
≥80% was obtained with 0.071 mg mL-1 of blumeoidolide B in comparison with ≥3.6 mg mL-
1 of blumeoidolide A.  Agar diffusion double ring assays indicated that only the activity of 
the LuxI synthase homologue, CviI, was modulated by blumeoidolides A and B, and V. 
blumeoides crude extracts, suggesting that QS signal synthesis was down-regulated or 
competitively inhibited.  Molecular docking was conducted to explore the binding 
conformations of sesquiterpene lactones into the binding sites of QS regulator proteins, CviR 
and CviR’.  The computed binding energy data suggested that the blumeoidolides have a 
tendency to inhibit both CviR and CviR’ with varying binding affinities.  Vernonia 
eudesmanolide sesquiterpene lactones have the potential to be novel therapeutic agents, 
which might be important in reducing virulence and pathogenicity of drug-resistant bacteria 
in vivo. 
 
Keywords: Vernonia blumeoides; Asteraceae; quorum sensing inhibition; molecular 
docking; sesquiterpene lactones, blumeoidolides 
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4.1 Introduction 
The increasing incidence of multi-drug resistant bacteria has prompted the search for potent, 
novel antibacterial drugs or complementary agents against resistant pathogens, with new 
targets or novel mechanisms, distinct from currently used antibacterial therapies.  One such 
target mechanism which has garnered interest has been quorum sensing (QS), a cell density-
dependent chemical signaling process, which is mediated by acyl homoserine lactones (AHL) 
in Gram-negative bacteria.  QS regulates gene expression in bacteria for collective biological 
functions and significantly influences bioluminescence, plasmid transfer, bacterial virulence, 
the biosynthesis of secondary metabolites and antibiotics, and biofilm formation (Hirakawa 
and Tomita, 2013).  Therefore, targeting QS mechanisms involving signal production, 
dissemination or reception could disrupt the QS circuits, curtail bacterial virulence and 
resistance (Hentzer and Givskov, 2003) and, furthermore, bacteria are unlikely to develop 
multi-drug resistance since no selection pressure is imposed (Koh et al., 2013). 
 
Plants have been used for centuries in traditional medicine due to their diverse secondary 
metabolites such as alkaloids, flavonoids, saponin glycosides, anthraquinones and 
sesquiterpenoids, among others.  All plants grow in environments with high bacterial 
densities and have developed an evolutionary co-existence with QS bacteria.  Plants have 
thus developed protective mechanisms against bacterial infections, e.g., being able to produce 
QS inhibitory compounds or QS mimic compounds, which reduce the pathogenic capability 
of bacteria (Koh et al., 2013; Nazzaro et al., 2013).  Due to their diverse chemical repertoire, 
the anti-virulence properties of medicinal plants and their constituent phytochemicals are 
attracting attention since plants are able to interfere with bacterial communication processes 
thereby disrupting associated cellular mechanisms or functions (Koh et al., 2013; Nazzaro et 
al., 2013).  Gram-negative bacteria primarily use the LuxR/I-type QS system.  Plant 
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compounds usually target these Gram-negative bacterial QS systems via three different ways, 
either by inhibiting the signaling molecules from being synthesized by the LuxI synthase, by 
inhibition of activity of AHL-producing enzymes, by degrading signaling molecules and/or 
by targeting the LuxR signal receptor (Koh et al., 2013; Nazzaro et al., 2013).  Since QS is 
crucial to bacterial cellular functions and survival, disrupting the QS signal production or 
reception, facilitates control of bacterial virulence and resistance (Hentzer and Givskov, 
2003).  
 
Plants of the genus Vernonia (Asteraceae) represent about 500 species distributed in tropical 
regions of the world especially in Africa and South America (Bremer, 1994).  Vernonia 
species, such as Vernonia amygdalina, is widely used in African traditional medicine due to 
its multiple therapeutic properties for various human and animal diseases (Yeap et al., 2010).  
Phytochemical studies on several Vernonia species have resulted in the isolation of 
flavonoids, triterpenoids and sesquiterpene lactones (SLs) with interesting biological 
activities (Toyang and Verpoorte, 2013).  In the Asteraceae particularly, SLs which are 
typically localised in leaves and flowering heads, are one of the main contributors to the 
plant’s defense mechanisms.  Since plants are constantly under microbial attack, SLs are able 
to provide defense against fungi, bacteria, and viruses, by disruption of a microbe’s cell 
membrane, due to their polar groups disrupting the phospholipid membrane.  Sesquiterpene 
lactones function as phytoalexins in response to microbial attack, as anti-feedants to deter 
herbivores, as attractants of pest predators, as hormones, and as allelochemicals (Chadwick et 
al., 2013).  Sesquiterpene lactones demonstrate a broad spectrum of biological activity 
including anti-tumor, anti-inflammatory anti-malarial, anti-viral, anti-bacterial, and anti-
fungal activity.  The QS and biofilm inhibitory potential of plant SLs has been reported by 
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Cartegena et al. (2007) and Amaya et al. (2012), while that of drimane sesquiterpenoids have 
been reported by Paz et al. (2013) and Cárcamo et al. (2014).  
 
The binding of the signal molecule to the sensor can be compared to that of a ligand binding 
to an enzyme active site.  According to Goh et al. (2005), it is important to analyze the 
binding of signal antagonists to the receptor protein in order to fully understand the inhibitory 
effect.  In this study, we report on the QS inhibitory potential of previously described 
eudesmanolide SLs (blumeoidolides) and crude extracts from Vernonia blumeoides Hook. f. 
(Asteraceae) (Aliyu et al., 2015) using Chromobacterium violaceum and Agrobacterium 
tumefaciens biosensor systems.  In addition, in silico molecular docking of the SLs 
(blumeoidolides A, B, C, and D) with LuxR homologues, CviR and CviR’ was carried out to 
confirm and assess the molecular characteristics of the protein-ligand interactions. 
 
4.2 Results and Discussion 
Chemical composition of extracts 
Table 4.1 indicates the chemical composition of four solvent extracts of V. blumeoides as 
identified by GC-MS analysis and using the NIST library.  Fatty acids/esters, terpenoids and 
steroids constituted the main classes of bioactive compounds.  The major components in the 
hexane (VBL-Hex), dichloromethane (VBL-DCM), ethyl acetate (VBL-EA) and methanol 
(VBL-MeOH) extracts were 2-(octadeca-9Z,12Z-dienyloxy) ethanol (5) (12.5%), 14,15-
epoxy-3,11-dihydroxy-(3β,5β,11α,15β)-bufa-20,22-dienolide (6) (33.5%), catechol (7) 
(19.5%) and 3,5-stigmastadien-7-one (8) (17.9%), respectively (Figure 4.1).  Of the main 
classes of bioactive compounds, terpenoids are ubiquitous components of plant extracts, but 
chemo-types vary in aggregate composition due to environmental influences or genetic 
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evolution (Figueiredo et al., 2008).  This probably determines the potency of biological or 
pharmacological action on microorganisms.  
Table 4.1  Chemical composition of four Vernonia blumeoides solvent extracts  
Chemical constituents RT a 










2-methyl-2Z-butenoic acid 4.3 - 1.6 - - 
2,3-dihydrobenzofuran 9.1 - 0.9 - - 
Catechol 9.3 - 19.5 - - 
1-Acetyl-2,5-dihydropyrrole-2-carboxylic acid 9.9 - 0.8 - - 
6-hydroxy-4-pyrimidine carboxylic acid 10.5 - 0.8 - - 
8-methoxy-1,3,4,5-tetrahydro-2H-1-benzazepin-2-
one 
12.6 - 2.3 - - 
4-(1E)-3-hydroxy-1-propenyl)-2-methoxyphenol 15.3 - 3.1 - - 
Phytol acetate 16.2 - 0.6 - - 
6,10,14-trimethyl-2-pentadecanone 16.3 - 1.9 6.4 1.3 
(Z)-non-3-enyl octyl adipate 17.0 - 0.8 - 8.0 
Hexadecanoic acid, 15-methyl, methyl ester- 17.1 - 0.7 - 1.8 
(3β,13β,14β)-13,27-Cycloursan-3-ol acetate 17.4 - - - 3.4 
Ascorbic acid, 2,6-dihexadecanoate 17.6 6.7 - 1.1 - 
n-Hexadecanoic acid 17.7 - 6.0 - 7.0 
n-Hexadecanoic acid ethyl ester 17.8 - 1.0 - - 
2-hexyldecan-1-ol 17.9 1.0 - - - 
(10E,12Z)-methyl octadeca-10,12-dienoate 18.8 0.8 - - 3.3 
Methyl 8-octadecenoate  18.9 0.6 - - 1.7 
Dihydro-5-tetradecyl-2(3H)-furanone 19.0 - - 1.0 - 
10Z,12Z-Hexadecadien-1-ol acetate  19.3 - - - 1.8 
9Z,12Z-octadecadienoic acid  19.4 9.3 8.2 - - 
3-(1-ethoxy-1-oxo-5-phenylpentan-3-
yloxy)butanoic acid 
20.5 - 1.2 - - 
5-(2-dodecyl-4-methoxyphenoxy)-5-oxopentanoic 
acid 
20.7 - - 1.4 - 
5-methyl-5-(4,8,12-
trimethyltridecyl)dihydrofuran-2(3H)-one 
21.2 0.6 - - - 
8,8-dimethyl-2H, 8H-pyrano-(3, 2γ)-chromen-2-
one 
21.5 0.6 - - - 
11-Dodecyn-1-ol acetate  22.1 - - - 3.4 




22.3 - - - 9.0 
Glycidol stearate  22.4 - - 5.5 - 
(22E)-4-methyl stigmasta-4,22-dien-3-ester 22.5 - - - 0.9 
Lanosterol 22.7 - - 7.1 - 
Digitoxin 23.0 - - 3.6 - 
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Lupan-3-ol acetate  23.5 - - 6.9 4.6 
3,5-stigmastadien-7-one 24.7 - - - 17.9 
2-(3-acetoxy-4, 4,14-trimethyl andros-8-en-17-yl) 
propanoate 
24.8 - - 1.6 - 
2, 4'-isopropylidene diphenol 25.0 3.0 - - - 
Tetratetracontane 25.6 - - 2.4 - 
3-acetoxy-4,14-dimethyl-9,19-cycloergost-24(28)-
ene 
25.9 - - - 1.5 
β-amyrin acetate 26.2 1.1 4.6 - - 
3β-acetoxylanosta-8,24-diene 28.2 - - 3.2 - 
Lupeol 28.3 4.2 14.2 - - 
3-acetoxy-9,19-cyclolanostane 28.4 - - - 1.6 
4-hydroxy-4a, 5-dimethyl-3-methylene-3a, 4, 4a, 
5, 6, 7, 9, 9a-octahydronaphtho [2,3-b]furan-
2(3H)-one  
28.7 7.7 - - - 
3β-acetoxycholest-8-ene  29.0 - - - 3.3 
14,15-epoxy-3,11-dihydroxy-(3β,5β,11α,15β)-
bufa-20,22-dienolide 
29.3 33.5 - - - 
1-(4-isopropylphenyl)-3-(2-furyl) propane 29.6 1.4 - - - 
a Rt = retention time in min. 
b VBL-DCM = dichloromethane extract, VBL-EA = ethyl acetate extract, VBL-Hex = hexane extract, and VBL-
MeOH = methanol extract. 
 
 
Biosensor antimicrobial susceptibility testing  
The antimicrobial activity of crude extracts and eudesmanolide SLs from V. blumeoides 
against Gram-negative and Gram-positive indicator bacteria has already been reported (Aliyu 
et al., 2015).  Crude extracts and blumeoidolide A (1) (2 and 4 mg mL-1) were initially 
assessed for their antimicrobial effect against the biosensor and AHL over-producer strains 




Figure 4.1 Chemical structures of sesquiterpene lactones (1-4) isolated and major 
constituents identified by GC-MS (5-8) from Vernonia blumeoides. 
 
Quantitative anti-quorum sensing activity-violacein inhibition  
Inhibition of violacein pigment production by blumeoidolide A (1), blumeoidolide B (2) and 
four crude extracts (0.15 – 9.5 mg mL-1), all obtained from our previous study (Aliyu et al., 
2015), was measured spectrophotometrically and quantified (Figure 4.2).  Due to a lack of 
sufficient sample, the inhibition of violacein for blumeoidolides C (3) and D (4) also isolated 
in our previous study (Aliyu et al., 2015) could not be determined. This range of 
concentrations was used to identify the lowest concentration at which QS was evident, as 
well as document any potential growth inhibitory effect.  Given the limited yield of 
blumeoidolide B (2), QSI was investigated in a range of 0.003-0.19 mg mL-1.  Growth 
inhibition was observed at concentrations ≥5 mg mL-1 and these concentrations were not 
considered for QSI.   
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A concentration-dependent inhibition of violacein production by C. violaceum ATCC 12472 
was observed with ≤4.75 mg mL-1 blumeoidolide A (1) and four crude extracts (Figure 4.2), 
without inhibition of bacterial growth.  The differences in the mean values among the 
treatment groups was greater than would be expected by chance, thus there was a statistically 
significant difference (p < 0.001).  A similar concentration-dependent inhibition of violacein 
production has been reported with methanol extracts of dried Capparis spinosa fruit 
(Packiavathy et al., 2011), Cuminum cyminum extract (Packiavathy et al., 2012), and aqueous 
Moringa oleifera leaf and fruit extracts (Singh et al., 2009), without inhibiting bacterial 
growth.  Inhibition of violacein production ≥90% violacein was observed at concentrations of 
2.4 mg mL-1 of crude extracts.  The four V. blumeoides extracts displayed varying levels of 
QSI potency, with 90% inhibitory activity in the following order: VBL-EA > VBL-DCM > 
VBL-Hex > VBL-MeOH (Figure 4.2).  An 88% inhibition in violacein production was 
obtained with 2 mg mL-1 of the C. spinosa methanol extract (Packiavathy et al., 2011), while 
2 mg mL-1 of the C. cyminum methanol extract resulted in 90% inhibition (Packiavathy et al., 
2012). 
 
Table 4.2  Antimicrobial susceptibility profiles of biosensors following exposure to 2 mg 
mL-1 (sub-inhibitory concentration) of four crude Vernonia blumeoides extracts and 
blumeoidolide A (1) 
Bacteria VBL-
DCMa  




Ag. tumefaciens A136 9 (Rb) 0 (R) 9 (R) 0 (R) 10 (R) 
Ag. tumefaciens KYC6 10 (R) 0 (R) 10 (R) 10 (R) 10 (R) 
C. violaceum VIR07 9 (R) 8 (R) 9 (R) 8 (R) 9 (R) 
C. violaceum ATCC 12472 12 (I) 11 (I) 10 (R) 10 (R) 10 (R) 
C. violaceum CV026 12 (I) 10 (R) 12 (I) 12 (I) 12 (I) 
C. violaceum ATCC 31532 10 (R) 10 (R) 11 (I) 8 (R) 10 (R) 
a VBL-DCM = dichloromethane extract, VBL-EA = ethyl acetate extract, VBL-Hex = hexane extract, and VBL-
MeOH = methanol extract. 
b (R) and (I) denote resistance and intermediate susceptibility (Chenia, 2013). 
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Violacein inhibition of ≥85% was obtained with blumeoidolide A (1) with ≥3.6 mg mL-1 and 
22, 81 and 97% with 0.048, 0.071 and 0.095 mg mL-1 of blumeoidolide B (2), respectively.  
The IC50 for blumeoidolides A (1) and B (2) were 1.55 and 0.055 mg mL-1, respectively, 
while those of the crude extracts ranged from 0.45 (VBL-Hex) to 0.77 mg mL-1 (VBL-DCM).  
Blumeoidolide B (2) thus had a greater QSI effect than blumeoidolide A (1), since it inhibited 
violacein production at a much lower concentration.  The difference in structure between 
blumeoidolide A (1) and B (2) is the position of the acetyl group from C-1 on the bicyclic 
ring to C-17 on the open side chain (Figure 4.1).  This is indicative that the acetyl group on 



































Figure 4.2  Quantitative analysis of the concentration-dependent inhibitory effects of 
blumeoidolide A and four V. blumeoides crude extracts at 0.15-4.75 mg mL-1 (VBL-
DCM, VBL-EA, VBL-Hex, and VBL-MeOH) on violacein production by 
Chromobacterium violaceum ATCC 12472.  Data represents the mean±standard 
deviation of three independent experiments. 
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Qualitative modulation of QS activity 
In the AHL system, the signal-generating LuxI or its homologues, the N-acylhomoserine 
lactone (AHL) molecule itself, and the signal receptor LuxR or its homologues are potential 
targets.  Many natural extracts inhibit QS by interfering with the AHL activity by competing 
with them due to their structural similarity and/or accelerating the degradation of the LuxR 
receptors of AHL molecules (Koh et al., 2013; Nazzaro et al., 2013).  Interference with signal 
reception may involve competitive and non-competitive molecules which interfere with the 
binding of AHLs to their cognate LuxR receptor.  For competitive molecules to bind to the 
AHL receptor, they must be structurally similar to AHLs, while for non-competitive binding, 
these molecules will bind to a site on the receptor other than the AHL binding site.  Plants 
can produce molecules that structurally mimic AHLs, and such competitive binding is 
effective in blocking activation of QS (Koh et al., 2013).  A second level of modulation 
involves modulating the synthesis of AHL molecules by decreasing the expression of the 
LuxI family of synthases or the ability of phytochemicals to competitively or non-
competitively inhibit LuxI activity (Vattem et al., 2007).  Thus to determine whether 
potential inhibitors target AHL synthesis (via LuxI homologues) or AHL response (via LuxR 
homologues), a double ring bioassay was carried out using the C. violaceum and Ag. 
tumefaciens biosensor systems with a sub-inhibitory concentration of SLs, since the goal is 
not to kill bacterial cells but rather attenuate their virulence abilities by inhibition of QS-
regulated processes. 
 
In the CV026/ATCC 31532 system, only CviI (LuxI homologue in C. violaceum) inhibition 
(inhibition of short-chain C4-AHL and C6-AHL signal synthesis) was observed (Figure 4.3) 
to varying degrees: VBL-EA > VBL-MeOH > VBL-Hex > blumeoidolide B (2) > 
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blumeoidolide A (1) = VBL-DCM.  In the VIR07/ATCC 12472 assay, again only CviI 
modulation (inhibition of long chain C10-AHL signal synthesis) was observed in the 
following order: VBL-MeOH > VBL-EA > VBL-DCM > blumeoidolide A (1) > VBL-Hex 
(Figure 4.4). 
 
β-galactosidase expression in Ag. tumefaciens A136 is under the control of QS and is 
expressed in response to the presence of AHL molecules secreted by the AHL over-producer 
KYC6.  TraI (LuxI homologue in Ag. tumefaciens) inhibition was observed with 
blumeoidolide A (1) and VBL-MeOH and VBL-DCM, with decreased enzyme activity being 
indicated by decreased X-gal hydrolysis and blue pigment formation.  This was indicative of 
the respective extracts affecting 3-oxo-C8- and 3-oxo-C6-AHL synthesis only.  No inhibition 
was observed with VBL-EA and VBL-Hex.  No TraR (LuxR homologue in Ag. tumefaciens) 
inhibition was observed with any of the extracts tested.  The CviI modulatory effect was 
greater when using the VIR07/ATCC 12472 system in comparison to the TraI Ag. 
tumefaciens combination.   
 
Based on the CviI/TraI inhibition observed, it may be suggested that blumeoidolides A (1) and B 
(2) potentially modulated the ability of the over-producer bacteria to synthesize AHL molecules.  
Two scenarios might provide an explanation: the phytochemicals either decrease the expression 
of the CviI/TraI synthase, which synthesizes the AHL molecules, or decrease AHL synthesis due 
to their ability to competitively or non-competitively inhibit CviI/TraI activity (Vattem et al., 
2007; Mihalik et al., 2008).  Cartagena et al. (2007) evaluated 16 plant SLs, thirteen from the 
family Asteraceae, and three from the Hepaticaceae family, for their ability to inhibit or stimulate 
the production of biofilm by P. aeruginosa.  Six SLs from Acanthospermum hispidum and one 
from Enydra anagallis strongly inhibited (69 - 77%) biofilm formation at a concentration of 2.5 
mg mL-1.  The tested compounds carry a γ -lactone moiety, which is a structural feature similar to 
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the lactone moiety present in N-acyl homoserine lactones, and is a common structural feature of 
QS inhibitors (Ghantous et al., 2010).   
 
 
Figure 4.3  Quorum sensing inhibition by sub-inhibitory concentrations (2 mg mL-1) of 
blumeoidolide A (VBL 5-7), and 4 V. blumeoides crude extracts (VBL-DCM, VBL-
EA, VBL-Hex and VBL-MeOH) by A] modulation of AHL receptor activity (LuxR) 
or B] AHL synthesis (LuxI) in the double ring agar diffusion assay with the 
Chromobacterium violaceum VIR07/ATCC 12472 biosensor system.   Discs 
impregnated with 20 μL of sterile distilled water served as a control. 
 
The bioactivity of SLs is mediated by alkylation of nucleophiles through their, β- or α, β, γ-
unsaturated carbonyl structures, such as α-methylene-γ-lactones or α, β-unsaturated 
cyclopentenones.  These structural elements react with nucleophiles, especially the cysteine 
sulfhydryl groups in proteins by a Michael-type addition.  This interaction between SLs and 
protein thiol groups leads to reduction of enzyme activity (Chaturvedi, 2011).  Amaya et al. 
(2012) observed that six SLs of the goyazensolide and isogoyazensolide-type isolated from 
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Centratherum punctatum were good candidates for the development of new anti-virulence 
agents instead of being bactericidal.  Although these SL compounds were not able to 
completely inhibit bacterial growth at 100 - 500 µg/mL, they altered biofilm formation, 
elastase activity, and production of N-acyl-homoserine lactones by Pseudomonas aeruginosa 
ATCC 27853 (Amaya et al., 2012). 
 
Figure 4.4  Quorum sensing inhibition by sub-inhibitory concentrations (2 mg mL-1) of 
blumeoidolides A (VBL 5-7) and B (VBL-DCM 67-77), and 4 V. blumeoides crude 
extracts (VBL-DCM, VBL-EA, VBL-Hex and VBL-MeOH) by A] modulation of 
AHL receptor activity (LuxR) or B] AHL synthesis (LuxI) in the double ring agar 
diffusion assay with the Chromobacterium violaceum CV026/ATCC 31532 biosensor 
system.  Discs impregnated with 20 μL of sterile distilled water and cinnamaldehyde 
(50 μg/mL) served as controls. 
 
The other documented QS inhibition by sesquiterpenoids involved drimane sesquiterpenoids 
(polygodial, drimenol and drimendiol) isolated from Drimys winteri.  Drimendiol (800 
μg/mL) decreased violacein production by C. violaceum ATCC 12472 by 70% and decreased 
biofilm formation by Pseudomonas syringae (Paz et al., 2013).  Drymis winteri, Psoralea 
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glandulosa and Peumus boldus also displayed inhibitory activity against C. violaceum ATCC 
12472 (Cárcamo et al., 2014).  Two α, β unsaturated lactones, cinnamolide and valdiviolide, 
with the carbonyl on position 12 of the drimane skeleton were found to be inhibitors of QS; 
while five other drimane lactones were not active.  It is highly likely that blumeoidolides A 
(1) and B (2) are AHL mimics which competitively inhibit CviI/TraI activity.  The secretion 
of AHL signal mimic molecules by higher plants regulates its associated bacterial 
populations, either by limiting the activity of pathogens by affecting AHL-regulated 
behaviors or by activating protection by plant growth-promoting bacteria (Teplitski et al., 
2011). 
 
Evaluation of antagonistic activity of blumeoidolides through molecular docking 
analysis 
The availability of the 3D molecular structure of a chosen therapeutic target, particularly the 
region responsible for its chemical interactions, makes it possible to identify a compound 
capable of binding to the active site of receptor proteins using computational molecular 
modeling techniques (Barbosa da Silva et al., 2014).  When binding occurs, the properties of 
the protein change.  This technique can be used to identify quorum sensing inhibitors or 
modulators by examining their structure–activity relationships with AHL receptor protein 
LuxR and/or its homologues.   
 
The 3D structures of transcriptional regulators involved in QS from C. violaceum (Chen et 
al., 2011), Ag. tumefaciens (Vannini et al., 2002), and P. aeruginosa (Bottomley et al., 2007) 
have been elucidated.  Chromobacterium violaceum ATCC 31532 synthesizes violacein as a 
result of cell-to-cell communication using N-hexanoyl homoserine lactone (C6-AHL), which 
is detected via the LuxR-type protein CviR (PDB: 3QP5).  Recognition of this native signal 
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molecule by its receptor CviR is strongly antagonized by C8-AHL and C10-AHL.  CviR’ 
(PDB: 3QP1) is the LuxR receptor protein in C. violaceum ATCC 12472 which is activated 
by its cognate ligand, 3-hydroxy-C10-AHL, and responds to C10-AHL, while C6-AHL acts 
as a partial antagonist.  CviR’ shares 87% amino acid sequence identity to CviR (Chen et al., 
2011).  In order to substantiate the experimental observations and probe the binding modes of 
blumeoidolides A-D into the binding site of CviR’ (PDB: 3QP1), molecular docking 
simulations were performed.   
 
All four blumeoidolides A-D were flexibly docked using the Flexible Docking algorithm 
embedded in the Discovery Studio.  First, the native ligands (C10-AHL and C6-AHL) were 
re-docked into the binding site (BS) of CviR’ and CviR, respectively, to check the feasibility 
of the docking protocol.  The computed root mean square deviation of approximately 0.5 Å 
(for CviR) and 1.2Å (for CviR’) between their docked poses and X-ray structures (Figure 
4.5) indicated a good three dimensional structural correlation between them and validated the 
predictive efficiency of the docking procedure.  Docking of the four SLs was subsequently 
performed following the same procedure as used for the native ligands.   
 
All compounds docked successfully into the BS of CviR’ (3QP1) with good binding affinity 
as evidenced by the lower computed binding energies ranging between -20 to -44.5 kcal/ mol 
(Table 4.3) with the lowest BE value showing the strongest interaction with the receptor and 
vice-versa.  Blumeoidolide B (2) exhibited the strongest binding affinity (BE = -44.5 
kcal/mol) with CviR’, supporting its highest biological activity (inhibition ≥80%, 
concentration 0.071 mg mL-1) observed under experimental conditions.  The binding affinity 
of the remaining compounds for CviR’ (Table 4.3) followed the order: blumeoidolide D (4) 
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(BE = -43.3 kcal/mol) > blumeoidolide C (3) (BE = -22.1 kcal/mol) > blumeoidolide A (1) 
(BE = -20.0 kcal/mol).   
 
 
Figure 4.5  [A] Overlay of docked pose of C6-AHL (native ligand; in green sticks) with its 
X-ray structure (in red sticks) for 3QP5, with RMSD (all atoms)=0.5Å.[B] Overlay of 
docked pose of C10-AHL (native ligand, in green sticks) with its X-ray structure (in 
blue sticks) for 3QP1, with RMSD (all atoms)=1.2Å.   
 
Based on computed binding energy data, the order of inhibition of CviR (3PQ5) with SLs 
(Table 4.3) was as follows: blumeoidolide C (3) (BE = -101.8 kcal/mol) > blumeoidolide D 
(4) (BE = -33.0 kcal/mol) > blumeoidolide B (2) (BE = -18.4 kcal/mol) > blumeoidolide A 
(1) (BE = -14.0 kcal/ mol).  Blumeoidolide B (2) (BE = -18.4 kcal/mol) also exhibited 
stronger interaction with the CviR protein (3QP5) compared to blumeoidolide A (1) (BE = -
14.0 kcal/mol), although blumeoidolide C (3) was a stronger inhibitor of CviR rather than 
blumeoidolide B (2).   
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Table 4.3  Molecular docking energy (kcal/mol) of sesquiterpene lactones, blumeoidolides 




Docking score (kcal/mol) 
 
  CviR                   CviR' 
N-hexanoyl-AHL (natural ligand of CviR) -55.7 - 
N-decanoyl-AHL (natural ligand of CViR’) - -26.0 
Blumeoidolide A (1) -14.0 - 20.0 
Blumeoidolide B (2) -18.4 -44.5 
Blumeoidolide C (3) -101.8 - 22.1 
Blumeoidolide D (4) -33.0 -43.3 
 
AHL antagonists belonging to the lactone, thiolactone and furanone classes of organic 
compounds are most commonly investigated due to their structural similarities with that of 
naturally occurring AHL auto-inducers. AHLs or their analogues are characterised by a 
lactone head which is able to form a H-bond with the nearby Trp84 residue, while the acyl 
group forms H-bonds with Asp97, Tyr80 and Ser155.  The tail part is buried in a hydrophobic 
pocket made of Val, Leu and Ile residues (Ahmed et al., 2013).   
 
Based on molecular modelling studies, ligands acting as AHL antagonists usually possess a 
five-membered lactone ring with an acyl group as a spacer and a hydrophobic tail which 
facilitates binding of these ligands with the active site by H-bonding and hydrophobic 
interactions (Singh et al., 2015).  For CviR, the lactone carbonyl forms a direct H-bond with 
the conserved Trp84 residue, the acyl group –NH forms an H-bond with Asp97 and the 
carbonyl oxygen forms H-bonds with Tyr80 and Ser155 (Ahmed et al., 2013). 
 
In order to determine the mode of action of blumeoidolides, the complexes of blumeoidolides 
A - D with CviR (Figure 4.6) and CviR’ (Figure 4.7) were visualized to validate whether 
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these SLs inhibit QS by allosteric inhibition of the receptors or by competitive binding to the 
receptors. Only interacting amino acids of the protein are shown (in red lines), whereas the 
lactone pose is depicted in sticks (lemon color) format.  Hydrogen bonds are shown as green 
dotted lines and hydrophobic interactions are depicted with grey dotted lines.  Binding sphere 
is shown as a light-yellow sphere. 
 
The docked complex of blumeoidolide A (1) with CviR (3QP5) revealed the presence of a 
hydrogen bond with Trp84 in addition to hydrophobic interactions with amino acid residues 
Tyr80, Tyr88, Asp97, Ile99, Trp111, and Met135 (Figure 4.6A).  Blumeoidolide B (2), on 
the other hand, showed hydrophobic interactions only with Val75, Leu85, Tyr88, and Met89 
(Figure 4.6B).  Chen et al. (2011) explained the increased antagonistic activity of C10-AHL 
against CviR based on the flexible nature of Met89 in accommodating the ligand in the 
binding site.   
 
Blumeoidolide C (3) formed three hydrogen bonds: two with Trp84 and one with Ile99, and 
hydrophobic interactions with Leu85, Trp111, Phe126, Met135 and Ile153 (Figure 4.6C).  
Blumeoidolide D (4) also interacted with CviR through hydrogen bonding with Tyr80, Asp97 
and Ile153, and hydrophobic bonding with Leu72, Val75, Leu85, Tyr88, Met89, and Leu100 
(Figure 4.6D).  Ahmed et al. (2013) observed that the lactone carbonyl formed a direct 
hydrogen bond with the conserved Trp84 residue, the acyl group –NH formed a hydrogen 
bond with Asp97 and the carbonyl oxygen formed hydrogen bonds with Tyr80 and Ser155.  
Ahmed et al. (2013) and Singh et al. (2015) have observed similar hydrogen and hydrophobic 




Figure 4.6  Docked complex of blumeoidolide A (A), blumeoidolide B (B), blumeoidolide C 
(C) and blumeoidolide D (D) with CviR (PDB code: 3QP5).   
 
 
Figure 4.7  Docked complex of blumeoidolide A (A), blumeoidolide B (B), blumeoidolide C 
(C) and blumeoidolide D (D) with CviR’ (PDB code: 3QP1). 
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CviR’ shares 87% amino acid sequence identity to CviR (Chen et al., 2011) thus the 
interactions observed varied.  Blumeoidolide A (1) exhibited a donor-acceptor interaction 
between the oxygen (ester functionality) atom of Ala59 of CviR’ (3QP1), along with 
hydrophobic interactions with Phe43, Val47, Leu154, Leu171, and Leu174 (Figure 4.7A).  
Blumeoidolide B (2) also showed similar interactions as that of blumeoidolide A (1) with 
CviR’, forming a hydrogen bond with Ala59 through its ester oxygen, in addition to 
hydrophobic interactions with Ala31, Leu40, Phe43, Val47, Leu60, Ser152, Ile153, Leu154, 
Leu171 and Leu174 (Figure 4.7B).   
 
The higher number of hydrophobic interactions exhibited by blumeoidolide B (2) suggests its 
tighter fit into the binding site of CviR’, and may account for its stronger interaction (BE = -
44.5 kcal/mol, Table 4.3) with the receptor compared to blumeoidolide A (1) (BE = - 20.0 
kcal/mol, Table 4.3), and the higher activity observed under experimental conditions.  
Blumeoidolide C (3) exhibited two hydrogen bonds with Ala59 and Thr175, in addition to 
hydrophobic interactions with Leu41, Val47, Arg74, Leu154, Leu171, Leu174 and Ala181 of 
CviR’ (Figure 4.7C). 
 
Both hydrophobic (Ile34, Leu40, Leu41, Phe43, Val47, Leu171, Leu174, and Ala182) and 
hydrogen bonding (Ala59, Val75, Leu76 and Thr175) accounted for the binding of 
blumeoidolide D (4) with the CviR’ (Figure 4.7D). The basic interaction of the four SLs with 
CviR’ appears to involve Phe43, Val47, Ala59, Leu154, Leu171 and Leu174.  Overall, the 
docking results suggest that both the hydrogen bonding and hydrophobic forces play an 




General experimental procedures 
GC-MS analysis was carried out on an Agilent Technologies (6890 Series) GC coupled with 
a Mass Selective Detector (5973 Series).  It was equipped with an Agilent HP-5MS capillary 
column (0.25 µm film thickness) with dimensions 30 m (length) × 0.25 micron (I.D).  
Violacein was quantified using a UV-1800 UV-VIS spectrophotometer (Shimadzu, Japan).  
The system software was driven by Agilent Chemstation software.  All chemical reagents 
used were of analytical grade and were supplied by Sigma (Germany), or Merck (South 
Africa).  Blank discs for antimicrobial susceptibility testing were obtained from the MAST 
Group Ltd. (Merseyside, UK).   
 
Test samples 
The hexane (VBL-Hex), dichloromethane (VBL-DCM), ethyl acetate (VBL-EA) and 
methanol extracts (VBL-MeOH) and four SLs [blumeoidolide A (1), blumeoidolide B (2), 
blumeoidolide C (3) and blumeoidolide D (4)] obtained previously from Vernonia 
blumeoides (Asteraceae) (Aliyu et al., 2015), were used in the QS inhibitory assays.  The 
structures of compounds 1-4 were elucidated in our previous publication (Aliyu et al., 2015).   
 
Gas chromatography-mass spectrometry  
The four crude extracts were subjected to GC-MS analysis in order to identify other known 
secondary metabolites.  A sample ionization energy of 70 eV was used for GC-MS detection.  
Helium was used as the carrier gas at a pressure of 60 kPa, with the oven temperature 
programmed at 100 °C (for 2 min) to 280 °C (for 30 min) at a ramping rate of 4 °C per min.  
A DB-5 (Agilent) column was used and a 2 µL sample was manually injected.  The injection 
temperature was at 280 °C with a split ratio of 1:50. The system software was driven by 
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Agilent Chemstation software.  The relative amount of each component as a percentage was 
calculated by comparing the area of the peak to the total area.  The identification of the 
various compounds was carried out by comparing their fragmentation peaks with those of 
known compounds in the NIST/NBS 2005 mass spectral database of the GC-MS.  
 
Antibacterial susceptibility testing 
Antibacterial efficacy of the SL blumeoidolide A (1) and crude extracts against biosensor 
system strains was determined using the disc diffusion method (CLSI, 2012).  Blumeoidolide 
A (1) was dissolved in DMSO to a final concentration of 100 mg mL-1.  Blank discs (6 mm; 
MAST, UK) were impregnated with 2 and 4 mg mL-1 of the SL or crude extracts and allowed 
to dry.  Biosensor (Ag. tumefaciens A136, C. violaceum CV026 and VIR07) and over-
producer (Ag. tumefaciens KYC6, C. violaceum ATCC 12472 and ATCC 31532) strains were 
grown overnight on Luria-Bertani (LB) agar plates and re-suspended to a turbidity equivalent 
to that of a 0.5 McFarland standard.  Suspensions were used to inoculate Mueller-Hinton 
(MH) agar plates by streaking swabs over the entire agar surface followed by the application 
of the respective extract/lactone discs.  Plates were then incubated for 24 h at 30 °C.  Testing 
was done in triplicate and DMSO-impregnated discs served as the negative control.  Zone 
diameters were determined and averaged.  Antibacterial activity was determined by 
measuring the diameter of the inhibition zone (clear zone) formed around the well in 
millimeters and classified as follows: Resistant (R): ≤ 10 mm; Intermediate (I): 11-14 mm; 
Sensitive (S): ≥ 15 mm (Chenia, 2013).   
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Quantitative anti-quorum sensing activity-violacein inhibition 
Blumeoidolide A (1), blumeoidolide B (2) and four crude V. blumeoides extracts were 
screened for QS inhibitory properties using the violacein inhibition assay, with inhibition of 
the C. violaceum ATCC 12472 purple pigment, violacein, being indicative of anti-quorum 
sensing activity (McLean et al., 2004).  Chromobacterium violaceum ATCC 12472 was 
cultured overnight in 5 mL of LB broth at 30 °C with or without crude extracts and 
blumeoidolide A (1) in a concentration range of 0 - 9.5 mg mL-1.  For blumeoidolide B (2), 
concentrations ranged from 0.003 – 0.071 mg mL-1 due to insufficient sample being available 
from our previous isolation.  QS inhibition (QSI)-positive controls, cinnamaldehyde and 
vanillin (Sigma) were tested at concentrations of 0.008 - 2.05 mg mL-1.   
 
A 1 mL aliquot of culture was centrifuged at 13 000 rpm for 10 min. The culture supernatant 
was discarded and the resulting pellet of precipitated violacein was re-solubilised in 1 mL of 
DMSO, followed by centrifugation at 13 000 rpm for 10 min to precipitate the cells.  The 
supernatant (1 ml) was aliquoted and violacein was quantified using a UV-1800 UV-VIS 
spectrophotometer (Shimadzu, Japan) at a wavelength of 585 nm.  Tests were done in 
triplicate determinations (Truchado et al., 2012).  The following formula was used to 
calculate the percentage of violacein inhibition: percentage of violacein inhibition = (control 
OD585 nm - test OD585 nm / control OD585 nm) (Packiavathy et al., 2012).   
 
Differences in violacein inhibition with and without the addition of varying concentrations of 
extract was determined using pair-wise testing based on Student’s t-tests using SigmaStat 3.5 
(Systat Software Inc., San Jose, CA, USA), with p ≤ 0.05 being considered significant. 
Differences in violacein inhibition mean values between extracts were determined using one-
way repeated measures and ANOVA with p ≤ 0.05 being considered significant. To isolate 
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the extract or extracts that differed from the others, the Holm-Sidak multiple pairwise 
comparison procedure was carried out, with p ≤ 0.05 being considered significant. 
 
Qualitative modulation of QS activity 
The modulation of AHL activity and inhibition of AHL synthesis by V. blumeoides crude 
extracts and sesquiterpene lactones –blumeoidolides A (1) and B (2) was determined using 
agar diffusion double ring assays (Vattem et al., 2007) at sub-inhibitory concentrations (2 mg 
mL-1).  The effect on short chain AHL inhibition was investigated with the C. violaceum 
biosensor system consisting of biosensor strain CV026 and C. violaceum ATCC 31532 as the 
C6-AHL over-producer (McClean et al., 1997).  Two biosensor systems were used to 
investigate the effect on long chain AHL inhibition, i.e., the Ag. tumefaciens biosensor 
system consisted of the biosensor strain A136 (pCF218) (pCF372) and strain KYC6 as the 3-
oxo-C8- and 3-oxo-C6-AHL over-producer (Zhu et al., 1998), while the long chain C. 
violaceum biosensor system consisted of biosensor strain VIR07 and C. violaceum ATCC 
12472 as the C10-AHL over-producer (Morohoshi et al., 2008).   
 
Blumeoidolides A (1) and B (2) and four crude V. blumeoides extracts, at sub-inhibitory 
concentrations (2 mg mL-1), were impregnated on sterile filter paper disks and the AHL over-
producer and biosensor strains inoculated in concentric circles in proximity to the 
impregnated disks (Chenia, 2013).  All biosensor and over-producer strains were first 
assessed for their resistance to 2 mg mL-1 of blumeoidolide A (1) and the crude extracts.  
Potential LuxI homologue inhibition was assessed by placing the AHL over-producer in close 
proximity to the test substance and the AHL biosensor distally.  LuxR homologue inhibition 
was assessed by reversing the location of the AHL over-producer and biosensor strains.  
Modulation was inferred by observation of a lower signal from the AHL biosensor than from 
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the over-producer (Vattem et al., 2007).  For the Ag. tumefaciens A136 system, 20 μL of 5-
bromo-4-chloro-3-indolyl-β-D-galactopyranoside (X-gal, 20 mg mL-1 in DMSO) was spread 
evenly on LB agar plates and allowed to dry for 60 min, prior to inoculation.  Discs 
impregnated with cinnamaldehyde (50 μg/mL), vanillin (200 μg/mL) and water were used as 
controls. 
 
Evaluation of antagonistic activity of blumeoidolides through molecular docking 
analysis 
The 3D structural coordinates of transcription activator proteins CviR and CviR’ were 
retrieved from the Protein Data Bank (PDB code: 3QP5 and 3QP1, respectively).  The native 
ligands and water molecules were removed using the Discovery Studio visualizer.  The 
protonated states of the proteins were determined at physiological pH using the Prepare 
Protein algorithm in DS.  The minimization of proteins was subsequently performed using the 
conjugate gradient algorithm with the CHARMm force field to remove the bad contacts.  The 
conformational profile of all compounds (blumeoidolides A-D) was explored using the 
Generate Conformation algorithm, and the lowest energy conformation obtained was further 
optimized at density functional theory (DFT) level using DS.  Prior to docking, a binding 
sphere covering all the active site residues was generated using the Define and Edit Binding 
Site module embedded in Discovery Studio.  Docking of compounds was subsequently 
performed using the Flexible algorithm (Koska et al., 2008).  The best pose selected based on 
the scoring function (-CDOCKER energy) was subjected to binding energy calculations and 




The anti-virulence potential of eudesmanolide SLs from V. blumeoides was assessed via 
quantification of QS-controlled violacein production and qualitative modulation of QS 
activity and signal synthesis using agar diffusion double ring assays using three (C. 
violaceum and Ag. tumefaciens) biosensor systems.  Blumeoidolide B (2) demonstrated 
greater activity than blumeoidolide A (1) and both SLs were able to modulate CviI synthase 
activity.  The docking of blumeoidolides A – D into the binding sites of CviR and CviR’ 
suggested their differential binding affinities for the target proteins.  Based on biological and 
in silico investigations of the QS inhibitory potential of eudesmanolide SLs from V. 
blumeoides, it may be suggested that they have the potential to be novel anti-pathogenic 
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CHAPTER 5 SESQUITERPENE LACTONES FROM VERNONIA 
PERROTTETII AND THEIR QUORUM SENSING INHIBITORY 
ACTIVITY 
Abstract 
A new sesquiterpene lactone of the keto-hirsutinolide type, 13-acetoxy-1(4β),5(6)β-diepoxy-
8α-(senecioyloxy)-3-oxo-1,7(11)-germacradiene-12,6-olide 1, was isolated from the hexane 
extract of the leaves of Vernonia perrottetii in addition to the known sesquiterpene lactone, 
13-acetoxy-1,4β-epoxy-8α-(senecioyloxy)-3-oxo-1,5,7(11)-germacratriene-12,6-olide 2.  
Three common flavonoids (apigenin 3, luteolin 4 and velutin 5) were also isolated from the 
ethyl acetate and hexane extracts of the leaves.  The structures of the compounds were 
elucidated using 1H, 13C and 2D-NMR spectroscopy.  The antibacterial and quorum sensing 
inhibitory activities of compounds 1 and 2 and crudes extracts showed limited activity on 
Bacillus subtilis and Staphylococcus aureus, with no activity on Gram negative bacteria. 
However, the quorum sensing inhibitory (QSI) experiments indicated that the keto-
hirsutinolides (1 and 2) and the four crude extracts had interesting inhibitory activity on the 
biosensor organism Chromobacterium violaceum ATCC 12472 in the range of 0.33-5.25 mg 
mL-1, with compound 1 being the most effective at 0.33 mg mL-1.  
 




Vernonia perrottetii Sch. Bip. ex Walp. (Asteraceae) is an annual herb that grows up to 60 
cm high with leaves of 1-3 cm long. It is commonly found in abandoned fields in Northern 
Nigeria, where the leaves are widely used as purgative agents for gastrointestinal problems 
(Burkill, 1985; Hutchinson et al., 1963). Species within the genus Vernonia have been used 
in traditional medicine for decades across Africa and South America.  Its activity is probably 
due to secondary metabolites such as sesquiterpene lactones (SLs) found in most Vernonia 
species.  These compounds can be considered major biochemical markers within the genus 
(Seaman, 1982).  Sesquiterpene lactones such as guaianolides (Bohlmann et al., 1978), 
glaucolides (Williams et al., 2005), hirsutinolides (Pillay et al., 2007) and eudesmanolides 
(Aliyu et al., 2015) were isolated from African species of Vernonia.  
 
Plant-derived sesquiterpene lactones are promising in modern drug discovery since they 
contain interesting pharmacophores such as the α, β-unsaturated-γ-lactone group (Ghantous et 
al., 2010). A number of pharmacological activities including cytotoxicity (Buskuhl et al., 
2010), anti-inflammatory (Walshe-Roussel et al., 2013), antibacterial (Duraipandiyan et al., 
2012) and quorum sensing inhibitory activity (Amaya et al., 2012) have been attributed to the 
lactone moiety.  
 
The problem of antibacterial drug resistance has been a major concern in recent years and the 
discovery of effective phytochemicals to combat this has been a major research focus of 
many researchers in the field of drug discovery.  Quorum sensing (QS) has received attention 
in recent years since it is a cell density dependent bacterial communication system using 
signal molecules to co-ordinate gene expression that activates the transcription of resistance 
production, biofilm formation and virulence expression, especially in Gram negative bacteria 
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(Cámara et al., 2002). Quorum sensing mechanisms are critical to bacterial virulence and 
development of antibiotic resistance; hence its inhibition has become a novel strategy to 
control bacterial resistance.  
 
Secondary metabolites from plants have previously been reported as effective inhibitors of 
QS (Nazzaro et al., 2013). For instance, the sesquiterpene lactones goyazensolides (Amaya et 
al., 2012), 6-gingerol isolated from Zingiber officinale (Kim et al., 2015) and natural 
stilbenoids (Sheng et al., 2015) have all exhibited potent QS inhibitory activities.  In addition, 
blumeoidolides A and B from V. blumeoides demonstrated good QS inhibitory potential 
(Aliyu et al., 2016). In our continued investigation of chemical compounds from Vernonia 
and their QS inhibitory potential, we report on the isolation and structure elucidation of a new 
sesquiterpene lactone 1 together with a known related sesquiterpenoid 2 and three known 
flavonoids. The QS inhibitory potential of the two hirsutinolides 1 and 2 and the crude 
extracts were evaluated. 
 
5.2 Results and Discussion  
A novel sesquiterpene lactone 1 of the germacranolide type was isolated from the hexane 
extract of the leaves of Vernonia perrottetii. In addition, a known sesquiterpene lactone 13-
acetoxy-1,4β-epoxy-8α-(senecioyloxy)-3-oxo-1,5,7(11)-germacratriene-12,6-olide 2 
(Bohlmann et al., 1983) was isolated from the same extract.  Three known flavonoids 
apigenin 3 (Wawer and Zielinska, 2001), luteolin 4 (Li et al., 2008), and velutin 5 (Kang et 
al., 2011) were also isolated from the ethyl acetate (3-4) and hexane (5) extracts of the leaf 
(Figure 5.1).  The sesquiterpene lactone 2, was previously isolated from V. poskeana 
(Bohlmann et al., 1983).  The structures of the known compounds were determined from 
their 1H and 13C NMR spectra together with 2D NMR spectra and confirmed by comparing 
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the NMR data with those contained in literature (Bohlmann et al., 1983; Wawer and 
Zielinska, 2001; Li et al., 2008; Kang et al., 2011). Some assignments for the 1H NMR data 
for compound 2 contained in Bohlmann et al. (1983) were revised based on HMBC 
correlations and 13C NMR data provided, which are absent in Bohlmann et al. (1983).  
Germacranolides are the largest class of sesquiterpene lactones reported from Vernonia with 
hirsutinolides being the most frequently reported skeletal type. The two hirsutinolide 
compounds (1 and 2) and the crude extracts were evaluated for their QS inhibitory potential.  
 
Compound 1 was isolated as a brown crystalline solid with a m.p of 95-96 ºC and molecular 
formula of C22H24O9 as established by the EI-MS showing a molecular ion peak at 455.2 
[M+Na]+ calculated for C22H24O9Na.  Absorption bands at 1781 and 1713 cm-1 for the ester 
carbonyl and ketone group, respectively were observed. The 1H and 13C NMR spectra (Table 
5.1) showed resonances typical of the hirsutinolide type sesquiterpenoid similar to 13-
acetoxy-1,4β-epoxy-8α-(senecioyloxy)-3-oxo-1,5,7(11)-germacratriene-12,6-olide 2 
(Bohlmann et al., 1983), with characteristic resonances for the olefinic methine protons at δH 
5.69 (1H, s, H-19) and 5.44 (1H, s, H-2), the methine protons H-8 at δH 6.14 (1H, d, J=8.3 
Hz) and H-10 at δH 2.94 (1H, m), the geminal methylene protons at δH 4.81 and 4.96 (each 
1H, d, J=13.4 Hz, H-13a, H-13b) and five methyl resonances at δH 1.25 (3H, d, J =6.9 Hz, H-
14), 1.60 (3H, s, H-15), 1.91 (3H, s, H-21), 2.07 (3H, s, H-17), and 2.14 (3H, s, H-22).  The 
13C NMR spectrum showed the olefinic oxygenated carbon resonance C-1 at δC 195.3, C-2 at 
99.2 and the ketone at 201.8.  Three other carbonyl resonances at δC 165.6 (C-12 lactone), 
170.1 (C-16 ester) and 165.4 (C-18 ester) and two other olefinic carbon resonances at δC 
157.5 (C-7) and 133.6 (C-11) were also observed similar to compound 2, as was the 
oxygenated C-4 carbon resonance bearing the methyl group at δC 83.1.  However, a notable 
difference in comparison to compound 2 was the absence of the olefinic proton resonance of 
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H-5 at δH 5.87, which was replaced by δH 3.64 (an oxygenated methine resonance) and two 
deshielded oxygenated carbon resonances at δC 66.4 and 90.2 instead of the olefinic carbon 
resonances at δC 117.1 and 146.5 seen in 2.  This was indicative of the double bond at C-5 
being replaced by an epoxide.  The carbon resonance of δC 66.4 was typical for epoxides with 
δC 90.2 being more deshielded due to the oxygen from the lactone ring. 
 
The structure was confirmed by HMBC correlations from H-15 to C-5 and H-5 to C-4 and C-
6.  Other relevant HMBC correlations were H-2 to C-4; H-14 to C-1 and C-10; H-8 to C-18 
and H-13a/b to C-7, C-11 and C-16, confirming the positions of the double bond at C-1 and 
the 14-methyl 8α-senecioyloxy and 13-acetoxy groups (Figure 5.2).  The stereochemistry at 
the chiral centres of C-4, C-10 and C8, was assigned by comparing with the known related 
compound 2 since the methyl groups at C-4 and C-10 and the senecioyloxy group at C-8 had 
very similar proton resonances to that of compound 2.  The H-15 resonance was then used to 
assign the stereochemistry of H-5 as alpha, since a NOESY correlation was observed between 
H-5 and H-15.  The epoxide at C-5 and C-6 was thus assigned as beta.  Compound 1 was thus 
identified as 13-acetoxy-1(4β),5(6)β-diepoxy-8α-(senecioyloxy)-3-oxo-1,7(11)-
germacradiene-12,6-olide. This is the first report of sesquiterpene lactones from V. 
perrottetii. 
 
Keto hirsutinolides with a 3-oxo-1-desoxy-1,2-dehydro hirsutinolide-13-O-acetate moiety 
have previously been isolated from V. poskeana (Bohlmann et al., 1983), V. jugalis 
(Tsichritzis et al., 1991) and V. staehelinoides (Pillay et al., 2007).  
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Figure 5.1  Structures of compounds 1-5 isolated from the leaves of V. perrottetii  
 
 
Figure 5.2  HMBC correlations in compound 1 
 
The hirsutinolides 1-2 are biogenetically related to the glaucolides. However, Tully et al. 
(1987) have argued that the hirsutinolides are artefacts of isolation during column 
chromatography on silica gel.  It was also demonstrated that trans annular cyclization of 
glaucolides on silica under acidic conditions yielded 2 (Tully et al., 1987).  However, Pillay 
et al. (2007) have shown the hirsutinolides to exhibit characteristic TLC profiles before being 
subject to purification by column chromatography, supporting their existence as natural 
products.  It is quite possible that due to the conformation of the germacrene skeleton, 
biosynthetic transformations are responsible for glaucolides to be transformed into the 
hirsutinolides 1-2 (Minnaard et al., 1999). 
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Table 5.1  1H and 13C NMR data for compounds 1and 2 (in CDCl3, 400 MHz) 
No. 1  2  
 δH  δC δH  δC  
1 - 195.3 - 195.1 
2 5.44 (s) 99.2 5.45 (s) 99.4* 
3 - 201.8 - 202.3 
4 - 83.1 - 86.9 
5 3.64 (s) 66.4 5.87 (s) 117.1 
6 - 90.2 - 146.5 
7 - 157.5 - 152.1 
8 6.14 (d, J=8.3) 66.7 6.19 (br s) 65.0 
9α 2.71 (ddd, J= 6.0, 8.3, 14.4) 42.0 2.76 (ddd, J= 5.6, 7.7, 14.7) 40.0 
9β 1.76 (dd, J=11.9, 14.4) - 1.72 (m) - 
10 2.94 (m)# 30.7 3.02 (m)$ 31.5 
11 - 133.6 - 131.5 
12 - 165.6 - 166.4 
13a 4.81 (d, J=13.4) 54.9 4.92 (d, J=13.4) 55.8 
13b 4.96 (d, J=13.4) - 5.00 (d, J=13.4) - 
14 1.25 (d, J=6.9) 16.4 1.24 (d, J=7.0) 15.3 
15 1.60 (s) 17.3 1.59 (s) 21.0 
16 - 170.1 - 170.2 
17 2.07 (s) 20.6 2.02 (s)  20.7 
18 - 165.4 - 164.9 
19 5.69 (s) 114.7 5.64 (s) 114.6 
20 - 159.2 - 160.0 
21 1.91 (s) 27.6 1.89 (s) 27.6 
22 2.14 (s) 20.5 2.13 (s) 20.5 
*indicated by a slight hump in the spectrum; #,$ resonance is theoretically a ddq but appears as a septet# and 
sestet$ due to overlapping resonances.  Chemical shifts are given in ppm relative to the internal reference, 
tetramethyl silane (TMS). Coupling constants (J) are given in Hz. 
 
Antibacterial activity 
Of the four crude extracts tested, only the DCM extract showed good antibacterial activity 
against Bacillus subtilis and the two S. aureus strains (ATCC 29213 and methicillin-resistant 
ATCC 43300) (Table 5.2). The lactone 1 also showed good activity against Bacillus subtilis 
with 2 having weaker activity against the same strain.   
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Table 5.2  Antibacterial activity of crude extracts and keto-hirsutinolides 1 and 2 from 
Vernonia perrottetii 
Bacterial isolates Zone diameter (mm) 
 HEX DCM EtOAc MeOH 1 2 TET30 AMP10 
Bacillus subtilis ATCC6653 9(R) 20(S) 10(R) 11(I) 18(S) 12(I) 36(S) 40(S) 
Enterococcus faecalis ATCC 
51299 
0(R) 0(R) 0(R) 0(R) 0(R) 0(R) 22(S) 24(S) 
Enterococcus faecium ATCC 
19431 
0(R) 0(R) 0(R) 0(R) 0(R) 0(R) 22(S) 24(S) 
Staphylococcus aureus ATCC 
29213 
8(R) 15(S) 0(R) 0(R) 0(R) 14(I) 28(S) 25(S) 
Staphylococcus aureus ATCC 
43300 (methicillin resistant) 
10(R) 16(S) 0(R) 9(R) 9(R) 10(R) 26(S) 11(I) 
Staphylococcus saprophyticus 
ATCC 35552  
9(R) 0(R) 0(R) 0(R) 0(R) 0(R) 26(S) 11(R) 
Staphylococcus scuiri ATCC 
29062 
8(R) 14(I) 0(R) 8(R) 8(R) 12(I) 25(S) 34(S) 
Staphylococcus xylosus ATCC 
35033 
10(R) 0(R) 0(R) 8(R) 10(R) 0(R) 36(S) 32(S) 
Streptococcus agalactiae 
ATCC 13813 
0(R) 0(R) 0(R) 0(R) 0(R) 0(R) 27(S) 0(R) 
Streptococcus pyogenes 
ATCC 19615 
0(R) 0(R) 0(R) 0(R) 0(R) 0(R) 20(S) 34(S) 
Escherichia coli ATCC 25922 8(R) 7(R) 0(R) 8(R) 8(R) 0(R) 27(S) 20 
Escherichia coli ATCC 35218 9(R) 0(R) 0(R) 0(R) 0(R) 0(R) 23(S) 0(R) 
Klebsiella pneumoniae ATCC 
700603 
0(R) 0(R) 0(R) 0(R) 0(R) 0(R) 12(R) 0(R) 
Pseudomonas aeruginosa 
ATCC 27583 
9(R) 0(R) 0(R) 0(R) 0(R) 0(R) 15(I) 0(R) 
Pseudomonas aeruginosa 
ATCC 35032 
8(R) 0(R) 0(R) 0(R) 0(R) 0(R) 14(R) 0(R) 
*Crude extracts and compounds 1 and 2 were tested at 4 mg mL-1, AMP10=Ampicillin (10 µg) and TET30= 
Tetracycline (30 µg). HEX=Hexane, DCM= Dichloromethane, EtOAc=Ethyl acetate, MeOH=Methanol 
Resistant (R): ≤ 10 mm; Intermediate (I): 11-14 mm; Sensitive (S): ≥ 15 mm (Chenia, 2013).  The criteria for 
assigning susceptibility or resistance to AMP10 was as follows: (S) ≥ 17 mm, (I) = 14-16 mm, (R) ≤ 13 mm, 
while those for TE30 were: (S) ≥ 19 mm, (I) = 15-18 mm, (R) ≤ 14 mm (CLSI, 2012) 
 
Quorum sensing inhibitory activity 
All four crude extracts and compounds 1 and 2 demonstrated QSI potential based on the 
violacein inhibition assay.  Anomalously, no growth inhibition was observed with 2 at 
concentrations ≥ 5.25 mg mL-1.  Compound 2 had the most effective QSI, with ≥ 75% at 0.33 
mg mL-1.  Compound 1 demonstrated QSI ≥ 80% at 1.31 mg mL-1.  All tested samples 
demonstrated QSI ranging from 66-96% at 1.31 mg mL-1 (Figure 5.3).  There was a 
statistically significant difference (p ≤ 0.001) in the mean values among the treatment groups 
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based on concentration.  However, no statistically significant differences (p = 0.109) were 
observed between the crude extracts or compounds 1 and 2 (Figure 5.3). The effective QS 
inhibition of the hirsutinolide 2 surpassed the results of drimane sesquiterpenoids from 
Chilean flora both in concentration and potency (Cárcamo et al., 2014). This is an indication 
of the potential for 2 to have therapeutic significance.   
Extracts/Compounds































Figure 5.3  Quantitative analysis of the concentration-dependent, violacein production 
inhibitory effects of keto-hirsutinolides (1 and 2) and four Vernonia perrottetii crude 
extracts at 0.33-5.25 mg mL-1 (VP-DCM, VP-EtOAc, VP-HEX, and VP-MeOH) 
against Chromobacterium violaceum ATCC 12472. Data represents the 
mean±standard deviation of three independent experiments. 
 
5.3 Experimental 
General experimental procedures 
Solvents used for the extraction and purification were reagent grade and distilled prior to 
being used.  1H, 13C and 2D NMR spectra were recorded on a Bruker AvanceIII 400 MHz and 
600 MHz spectrometers. The spectra were referenced according to the deuteriochloroform 
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signals at δH 7.24 and δC 77.0 and dimethyl sulfoxide δH 2.50, δc 39.51 (for 1H NMR and 13C 
NMR spectra, respectively). The HREIMS was measured on a ThermoFinnigan trace 132 
GC, coupled with a Polaris Q mass spectrometer.  IR spectra were recorded using a Perkin 
Elmer Universal ATR spectrometer. Optical rotations were measured at room temperature on 
a Perkin ElmerTM Model 341 Polarimeter with a 10-cm flow tube. UV spectra were obtained 
on a Varian Cary UV-VIS Spectrophotometer. The melting points were determined on an 
Ernst Leitz Wetziar micro-hot stage melting point apparatus. Merck silica gel 60 (0.040–
0.063 mm) was used for column chromatography and Merck 20 cm x 20 cm silica gel 60 F254 
aluminium sheets were used for TLC. The TLC plates were analyzed under UV (254 and 366 
nm) before being sprayed and developed with anisaldehyde: concentrated sulfuric acid: 
methanol spray reagent. 
 
Plant material 
Vernonia perrottetii was collected in August, 2011 along Giwa Road in Samaru-Zaria, 
Kaduna State. It was authenticated by U.S. Gallah at the Herbarium unit of the Department of 
Biological Sciences, Ahmadu Bello University, Zaria, Nigeria where a voucher specimen (no. 
250) was deposited. 
 
Extraction and isolation   
The dried leaves (1 kg) was subjected to sequential extraction with hexane (Hex), 
dichloromethane (DCM), ethyl acetate (EtOAc) and methanol (MeOH) and all extracts were 
concentrated under reduced pressure on a rotary evaporator to yield 18.20, 25.50, 15.80 and 
22.60 g of extract, respectively.  
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The hexane extract (15.2 g) was separated by column chromatography with a Hex: DCM 
gradient starting with 100% hexane and gradually increasing the polarity by 10% DCM every 
500 mL until 100% DCM was reached.  Fraction 68-79 (120 mg) was purified on a small 
column (2.5 cm in diameter) using Hex: DCM (2:3), where fractions 23-26 yielded yellowish 
crystals for compound 2 (40 mg), fractions 32-39 yielded compound 1 (48 mg) as brown 
crystals and fractions 48-59 yielded compound 5 (15 mg) as a yellow amorphous residue.   
 
The EtOAc extract (10.00 g) was separated on a silica gel column and eluted with a hex: 
EtOAc gradient (1:1, 4:6 and 3:7) collecting 20 mL fractions. Fractions 67-74 eluted with 
hex:EtOAc (4:6) yielded a yellowish residue as compound 3 (18 mg). Fractions 145-157 
eluted with hex:EtOAc (3:7) were combined and purified with hex:EtOAc (1:1), which 
yielded a yellowish compound from fractions 16-20 as 4 (25 mg).  
 
Antibacterial susceptibility testing 
Antibacterial efficacy of the SLs 1 and 2, and the four crude extracts was assessed against 10 
Gram-positive bacterial strains (Bacillus subtilis ATCC 6633, Enterococcus faecalis ATCC 
51299, Enterococcus faecium ATCC 19434, Staphylococcus aureus ATCC 29213, 
Staphylococcus aureus ATCC 43300, Staphylococcus saprophyticus ATCC 35552, 
Staphylococcus xylosus 35033, Staphylococcus sciuri ATCC 29062, Streptococcus 
agalactiae ATCC 13813, and Streptococcus pyogenes ATCC 19615) and five Gram-negative 
bacterial strains (Escherichia coli ATCC 25922, Escherichia coli ATCC 35218, Klebsiella 
pneumoniae ATCC 700603, Pseudomonas aeruginosa ATCC 27853, Pseudomonas 
aeruginosa ATCC 35032) using the disc diffusion method (CLSI, 2012).   
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Crude extracts and compounds 1 and 2 were dissolved in DMSO to a final concentration of 
100 mg mL-1.  Blank discs (6 mm; MAST, UK) were impregnated with 4 mg mL-1 of the SLs 
or crude extracts and allowed to dry.  Indicator bacteria were grown overnight at 37 °C on 
Tryptic soy agar plates and resuspended to a turbidity equivalent to that of a 0.5 McFarland 
standard.  Suspensions were used to inoculate Mueller-Hinton (MH) agar plates by streaking 
swabs over the entire agar surface followed by the application of the respective 
extract/lactone discs.  Plates were then incubated for 24 h at 37 °C.  Tetracycline (TE30) and 
ampicillin (AMP10) discs (Oxoid, UK) were used as standard antimicrobial agent controls, 
while DMSO-impregnated discs were used as negative controls. Zone diameters were 
determined and averaged.  Antibacterial activity was determined by measuring the diameter 
of the inhibition zone (clear zone) formed around the well in millimeters and classified as 
follows: Resistant (R): ≤ 10 mm; Intermediate (I): 11-14 mm; Sensitive (S): ≥ 15 mm 
(Chenia, 2013).  The criteria for assigning susceptibility or resistance to AMP10 was as 
follows: (S) ≥ 17 mm, (I) = 14-16 mm, (R) ≤ 13 mm, while those for TE30 were: (S) ≥ 19 
mm, (I) = 15-18 mm, (R) ≤ 14 mm (CLSI, 2012). 
   
Quantitative anti-quorum sensing activity-violacein inhibition 
SLs 1 and 2, and four crude V. perrottetii extracts were screened for QS inhibitory properties 
using the violacein inhibition assay, with inhibition of the C. violaceum ATCC 12472 purple 
pigment, violacein being indicative of anti-quorum sensing activity (McLean et al., 2004).  
Chromobacterium violaceum ATCC 12472 was cultured overnight in 3 mL of LB broth at 30 
°C with or without crude extracts and SLs 1 and 2 between 0-5.25 mg mL-1.  QS inhibition 
(QSI)-positive controls, cinnamaldehyde and vanillin (Sigma) were tested at concentrations 
of 0.008-2.05 mg mL-1.  One mL of culture was aliquoted and centrifuged at 13 000 rpm for 
10 min.  The culture supernatant was discarded and the resulting pellet of precipitated 
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violacein was resolubilised in 1 mL of DMSO, followed by centrifugation at 13000 rpm for 
10 min to precipitate the cells.  The supernatant was aliquoted (1 mL) and violacein was 
quantified using a UV-1800 UV-VIS spectrophotometer (Shimadzu, Japan) at a wavelength 
of 585 nm.  Tests were done in three independent experiments (Truchado et al., 2012).  The 
following formula was used to calculate the percentage of violacein inhibition: percentage of 
violacein inhibition = (control OD585 - test OD585 / control OD585) (Packiavathy et al., 2012).   
 
Differences in violacein inhibition with and without the addition of varying concentrations of 
extract was determined using pair-wise testing based on Student’s t-tests using SigmaStat 3.5 
(Systat Software Inc., San Jose, CA, USA), with p ≤ 0.05 being considered significant. 
Differences in violacein inhibition mean values between extracts were determined using one-
way repeated measures and ANOVA with p ≤ 0.05 being considered significant. To isolate 
the extract or extracts that differed from the others, the Holm-Sidak multiple pairwise 
comparison procedure was carried out, with p ≤ 0.05 being considered significant. 
 
5.4 Conclusion  
Keto-hirsutinolides were isolated from the leaves of V. perrottetii and their structures 
elucidated using spectroscopic information including 2D-NMR. This is the first report of 13-
acetoxy-1(4β),5(6)β-diepoxy-8α-(senecioyloxy)-3-oxo-1,7(11)-germacradiene-12,6-olide (1) 
and the first report of sesquiterepene lactones from Vernonia perrottetii. The crude extracts 
and 13-acetoxy-1(4β),5(6)β-diepoxy-8α-(senecioyloxy)-3-oxo-1,7(11)-germacradiene-12,6-
olide (1) and 13-acetoxy-1,4β-epoxy-8α-(senecioyloxy)-3-oxo-1,5,7(11)-germacratriene-
12,6-olide (2) have limited antimicrobial activity against selected Gram-positive bacteria 
belonging to the genera Bacillus and Staphylococcus, with no antimicrobial activity against 
the recalcitrant Gram-negative bacteria. Both the keto-hirsutinolides (1 and 2) and four V. 
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perrottetii crude extracts demonstrated QSI activity in the range of 0.33-5.25 mg mL-1, with 2 
being the most effective at 0.33 mg mL-1, suggesting a potential candidate for the 
development of antibiotics.  
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CHAPTER 6 BIOACTIVE COMPOUNDS FROM VERNONIA AMBIGUA 
AND VERNONIA GLABERRIMA AS QUORUM SENSING INHIBITORS 
Abstract 
The leaf extract of Vernonia ambigua was found to contain a novel sesquiterpene lactone, 
5,6-dehydrobrachycalyxolide 3.  In addition, the ubiquitous lupeol 1 and lupeol acetate 2 and 
a flavonoid, chrysoeriol 4 were isolated from the same extract. The leaf extract of Vernonia 
glaberrima was found to contain 1, 2 and 4 as well as three other flavonoids, velutin 5, 
luteolin 3',4'-dimethyl ether 6 and apigenin 7. The discovery of the sesquiterpene 3 provides a 
missing link between brachycalyxolide and isobrachycalyxolide.  The antibacterial activity of 
the crude extracts from V. ambigua and V. glaberrima was poor except for the effect that the 
hexane and dichloromethane extracts of V. glaberrima had on methicillin resistant 
Staphylococcus aureus (MRSA). Quorum sensing (QS) inhibitory activity of the triterpenoids 
lupeol 1, lupeol acetate 2 and 5,6-dehydrobrachycalyxolide 3 and all crude extracts showed 
inhibition ≥84% with 1, 2 and 3 at 2.6 mg mL-1, while those of the crude extracts ranged from 
61-92% at the same concentration. However, the qualitative QS inhibition of 1-3 and crude 
extracts, using double ring assays, showed predominant activity of the LuxI synthase 
homologue, indicating that CviI was modulated by all tested compounds and extracts. This 
suggests that short chain QS signal synthesis was down-regulated or competitively inhibited 
in the order: methanol extracts > ethyl acetate extracts > brachycalyxolide (3) > 
dichloromethane extracts for V. ambigua, and lupeol (1) > dichloromethane extracts > lupeol 
acetate (2) > hexane extracts for V. glaberrima. The long chain QS signal synthesis was also 
down-regulated or competitively inhibited, though to a lesser degree.   
 
Keywords: Vernonia ambigua, Vernonia glaberrima, triterpenoids, sesquiterpene lactone, 
quorum sensing inhibition. 
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6.1 Introduction 
Plants of the genus Vernonia (Schreb) are distributed in the tropical regions especially Africa 
and South America, where about sixty species have been found in West Africa (Hutchinson 
and Dalziel, 1963). Several Vernonia species are used as vegetable foods and herbal remedies 
in African traditional medicine (Yeap et al., 2010). Vernonia ambigua (Kotschy & Peyr) is a 
plant of approximately 18 inches in height with mauve coloured flowers. The leaves are used 
as a remedy for cough, fever and malaria (Kunle and Egharevba, 2009). Vernonia glaberrima 
(Welw. ex O. Hoffm) is an erect shrub about 3-4 feet high with a white flower head. In 
Northern Nigeria, the leaves are used as an analgesic, anti-inflammatory and anti-microbial 
agent (Abdullahi et al., 2015). Since it is widely used in traditional medicine, several 
Vernonia species have been studied for their antibacterial (Aliyu et al., 2011), anti-
inflammatory (Pandey et al., 2014) and antimalarial (Adebayo and Krettli, 2011) activities. 
These studies have been in many cases accompanied by phytochemical analyses resulting in 
the isolation of flavonoids (Seetharaman and Petrus, 2004), triterpenoids (Kiplimo, 2016) 
steroidal glycosides (Ma et al., 2016) and sesquiterpene lactones (Aliyu et al., 2015), among 
others. 
 
In recent years, antipathogenic properties of medicinal plants have attracted widespread 
attention due to the modulating effects of plant extracts against bacterial virulence 
(Yarmolinsky et al., 2015) through quorum sensing (QS) and related properties (Packiavathy 
et al., 2012; Truchado et al., 2012).  QS is a bacterial communication system involving signal 
molecules such as the acyl homoserine lactones (AHLs) used to regulate group behavior of 
bacterial cellular functions in Gram negative bacteria. They bind to specific receptor proteins 
when secreted out of neighboring bacterial cell walls, activating the transcription of 
resistance production, biofilm formation, virulence factor expression, bioluminescence and 
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pigment production (Cámara et al., 2002). The mechanisms of QS and related cellular 
functions are essential to survival of intercellular bacteria. Hence disrupting the QS signals 
was demonstrated to be a novel strategy for controlling bacterial virulence and resistance 
(Hentzer and Givskov, 2003).  
 
Previous reports have shown the efficacy of plant chemicals as QS inhibitors (Amaya et al., 
2012; Nazzaro et al., 2013; Yarmolinsky et al., 2015; Aliyu, et al., 2016). In our continued 
investigation of chemical compounds from Vernonia and their QS inhibitory potential, we 
report on the isolation and structure elucidation of a novel sesquiterpenoid in addition to 
known triterpenoids and flavonoids and on their QS inhibitory activity.  
 
6.2 Results and discussion 
The leaf extract of Vernonia ambigua (Kotschy and Peyr.) yielded the triterpenoids lupeol 1, 
lupeol acetate 2, a novel sesquiterpene, 5,6-dehydrobrachycalyxolide 3 and a flavonoid, 
chrysoeriol 4. The leaf extract of Vernonia glaberrima (Welw. ex O.Hoffm.) was found to 
contain the triterpenoids 1 and 2, the flavonoid 4 and three additional flavonoids, velutin 5, 
luteolin 3',4'-dimethyl ether 6 and apigenin 7 (Figure 6.1). The known compounds were 
identified from their 1H and 13C NMR spectra and confirmed by comparison with data from 
literature (Nakanishi et al., 1985; Wawer and Zielinska, 2001; Park et al., 2007; Jamal et al., 




Figure 6.1  Compounds isolated from V. ambigua [1-4] and V. glaberrima [1-2 and 4-7] 
 
The dichloromethane leaf extract of V. ambigua yielded a glaucolide sesquiterpene 3, with a 
1H NMR spectrum very similar to that of brachycalyxolide, previously isolated from V. 
brachycalyx (Jakupovic et al., 1987; Oketch-Rabah et al., 1998).  It was isolated as a 
crystalline solid with a melting point of 92-93 ºC and optical rotation of 62º. An ester 
carbonyl absorption band was evident in the IR spectrum at 1755 cm-1. The 1H NMR 
spectrum showed the presence of four methyl resonances, three singlets at δH 1.34, 1.50 and 
2.08, the first two assigned to two methyl groups on the ten carbon cylic ring framework, H-
14 and H-15, and the third to an acetyl methyl group, H-21 located on C-11 of the lactone 
ring.  The fourth methyl resonance at δH 2.32 (J = 7.2 Hz) was seen coupled to a very 
deshielded quartet at δH 6.70 (J = 7.2 Hz).  This was characteristic of the vinylic proton and 
vinylic methyl group, H-17 and H-18, respectively.  H-17 showed a HMBC correlation to the 
oxygenated singlet carbon resonance at δC 89.5.  The H-13 methylene group appeared as two 
coalescing doublets at δH 4.95 and 4.91 with J = 12.5 Hz and could be seen correlated the two 
olefinic resonances C-7 and C-11 and the lactone carbonyl C-12 all in the lactone ring as well 
as the acetyl carbonyl resonance, C-20.   
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The two methylene protons at C-24 appear as singlets at δH 6.02 and 6.37 and showed long 
range coupling to the methylene proton resonance at δH 4.35, which was then assigned to H-
25.  H-8 appeared as a broadened singlet at δH 5.95 due to the -O-C-H group and H-5 as a 
singlet at δH 6.06.  H-8 showed HMBC correlations to the lactone carbons C-6 and C-7 at δC 
147.9 and 152.1 and H-5 showed HMBC correlations to C-4, C-3 and C-15 at δC 83.4, 39.7 
and 31.8, respectively.  The methylene protons, H-2, H-3 and H-9 all appear between δH 2.38 
and 2.79.  The four carbonyl resonances are seen at δC 165.5 (C-22), 167.16 (C-19), 167.24 
(C-12) and 170.4 (C-20) in the 13C NMR spectrum and were assigned based on HMBC 
correlations; H-24 with C-22, H-21 with C-20, H-13 with C-12 and H-18 with C-19.  The 
stereochemistry at C-1, C-4, C-8 and C-10 was assigned on the basis of brachycalyxolide, 
since the NMR data was similar.  This was supported by NOESY correlations between H-17 
and H-15 and between H-14β and H-8β.  Compound 3 was thus identified as 5,6-
dehydrobrachycalyxolide and is the intermediate in the biosynthetic sequence from 
brachycalyxolide to isobrachycalyxolide (Jakupovic et al., 1987) (Figure 6.2). 
 
 
Figure 6.2  Biosynthetic pathway from brachycalyxolide to isobrachycalyxolide 
incorporating 5,6-dehydrobrachycalyxolide 3 
 
Antibacterial activity 
Both V. ambigua and V. glaberrima crude extracts demonstrated no antimicrobial activity 
against the panel of sensitive and resistant bacteria. The only exception was the effect that V. 
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glaberrima hexane and dichloromethane extracts had on methicillin-resistant S. aureus 
(MRSA) (Table 6.1). The importance of the Vernonia species as remedies for infectious 
diseases is validated due to the susceptibility of hospital associated infectious pathogens 
(MRSA) to V. glaberrima extracts. This corroborates previous reports on the efficacy of V. 
oocephala chloroform extracts to MRSA (Aliyu et al., 2011).  However, Vernonia species 
have generally been observed to exhibit activity toward Gram positive bacteria, perhaps due 
to easy penetration of plant chemicals through the bacterial cell wall. 
 
Table 6.1  Antibacterial susceptibility of V. ambigua and V. glaberrima extracts 
Zone diameter (mm) 
 E. coli P. aeruginosa S. aureus S. sciuri S. xylosus 
Extract ATCC 








29213      
ATCC 
43300      
ATCC 
29062   
ATCC 
35033 
V. ambigua         
Hex 9 (R) 10 (R) 7 (R) 10 (R) 7 (R) 12 (I) 8 (R) 0 (R) 
DCM 8 (R) 10 (R) 10 (R) 8 (R) 0 (R) 12 (I) 10 (R) 11 (I) 
EA 10 (R) 7 (R) 9 (R) 10 (R) 0 (R) 12 (I) 7 (R) 11 (I) 
MeOH 7 (R) 7 (R) 8 (R) 9 (R) 0 (R) 8 (R) 7 (R) 7 (R) 
V. glaberrima         
Hex 10 (R) 9 (R) 10 (R) 11 (I) 0 (R) 16 (S) 10 (R) 12 (I) 
DCM 10 (R) 10 (R) 10 (R) 9 (R) 0 (R) 16 (S) 12 (I) 10 (R) 
EA 10 (R) 7 (R) 8 (R) 8* (R) 0 (R) 9 (R) 10 (R) 12 (I) 
MeOH 8 (R) 7 (R) 8 (R) 10* (R) 0 (R) 10 (R) 9 (R) 10 (R) 
AMP10 20 (S) 0 (R) 0 (R) 0 (R) 25 (S) 20 (S) 32 (S) 34 (S) 
TET30 27 (S) 23 (S) 14 (I) 15 (I) 28 (S) 36 (S) 30 (S) 25 (S) 
* Loss of pyocyanin pigmentation was observed. AMP10 = Ampicillin at 10 µg, TET30= Tetracycline at 30 µg. 
Resistant (R): ≤ 10 mm; Intermediate (I): 11-14 mm; Sensitive (S): ≥ 15 mm (Chenia, 2013) 
 
Quantitative anti-quorum sensing activity-violacein inhibition 
Inhibition of violacein pigment production by V. ambigua and V. glaberrima crude extracts 
and compounds 1-3 (0.33-10.5 mg mL-1), was measured spectrophotometrically and 
quantified (Figure 6.3 and Figure 6.4).  This range of concentrations was used to identify the 
lowest concentration at which QS was evident, as well as document any potential growth 
inhibitory effect. Growth inhibition was observed at concentrations ≥7.87 mg mL-1 and these 
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concentrations were not considered for QSI. For 5,6-dehyrobrachycalyxolide (3), a 
concentration-dependent inhibition of violacein production by C. violaceum ATCC 12472 
was observed, up to 86% at 5.25 mg mL-1, while for the four V. ambigua crude extracts, 
inhibition ranged between 92-96% at the same concentration (Figure 6.3), with minimal 
bacterial growth inhibition. The four V. ambigua extracts displayed varying levels of QSI 
potency, with as much as 80% or greater inhibitory activity at 2.62 mg mL-1 in the following 
order: 5,6-dehydrobrachycalyxolide (3) > V. ambigua dichloromethane (VA-DCM) > V. 
ambigua methanol (VA-MeOH) > V. ambigua hexane (VA-Hex) > V. ambigua ethyl acetate 
(VA-EtOAc) (Figure 6.3).  The IC50 for 5,6-dehydrobrachycalyxolide (3) and the four V. 
ambigua crude extracts was within the range of 1-1.5 mg mL-1.  The differences in the mean 
values among the treatment groups was not statistically significant (p = 0.069).   
 
Figure 6.3  Quantitative analysis of the concentration-dependent, violacein production 
inhibitory effects of 5,6-dehydrobrachycalyxolide (3) and four Vernonia ambigua crude 
extracts at 0.33-5.25 mg mL-1 (VA-DCM, VA-EA, VA-Hex, and VA-MeOH) on 
Chromobacterium violaceum ATCC 12472. Data represents the mean±standard deviation of 
three independent experiments. 
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For lupeol (1) and lupeol acetate (2) a concentration-dependent inhibition of violacein 
production by C. violaceum ATCC 12472 was observed, up to 94% at 5.25 mg mL-1, while 
for the four V. glaberrima crude extracts inhibition ranged between 90-96% at the same 
concentration (Figure 6.4), with minimal bacterial growth inhibition. The four V. glaberrima 
extracts displayed varying levels of QSI potency, with ≥70% inhibitory activity at 2.62 mg 
mL-1 in the following order: V. glaberrima dichloromethane (VG-DCM) > V. glaberrima 
ethyl acetate (VG-EA) > lupeol (1) > lupeol acetate (2) > V. glaberrima hexane (VG-Hex) > 
V. glaberrima methanol (VG-MeOH) (Figure 6.4).  There was a statistically significant 
difference (p = 0.007) in the mean values among the treatment groups.   
Pure Compound/Extracts



























5.25 mg/ml   
Figure 6.4  Quantitative analysis of the concentration-dependent, violacein production 
inhibitory effects of lupeol (1), lupeol acetate (2) and four Vernonia glaberrima crude 
extracts at 0.33-5.25 mg mL-1 (VG-DCM, VG-EA, VG-Hex, and VG-MeOH) on 
Chromobacterium violaceum ATCC 12472. Data represents the mean±standard deviation of 
three independent experiments. 
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Qualitative modulation of QS activity 
Potential targets in the acyl homoserine lactone (AHL) system are the signal-generating LuxI 
or its homologues, the N-acyl homoserine lactone molecule itself, and the signal receptor 
LuxR or its homologues. Many natural extracts inhibit QS by interfering with the AHL 
activity by competing with them due to similar structure and/or accelerating the degradation 
of the LuxR receptors of AHL molecules (Koh et al., 2013; Nazzaro et al., 2013). 
Interference with signal reception may involve competitive and non-competitive molecules 
which interfere with the binding of AHLs to their cognate LuxR receptor. For competitive 
molecules to bind to the AHL receptor, they must be structurally similar to AHLs, while for 
non-competitive binding, these molecules will bind to a site on the receptor other than the 
AHL binding site. Plants can produce molecules similar to the AHLs moieties, and such 
competitive binding is effective in blocking activation of QS (Koh et al., 2013). A second 
level of modulation involves modulating the synthesis of AHL molecules by decreasing the 
expression of the LuxI family of synthases or the ability of phytochemicals to competitively 
or non-competitively inhibit LuxI activity (Vattem et al., 2007).  Thus, the double ring 
bioassay was carried out using two C. violaceum biosensor systems to determine whether 
potential inhibitors target AHL synthesis (via LuxI homologues) or AHL response (via LuxR 
homologues).   
 
In order to assess the correct concentration to be used for the assay, biosensor strains were 
subjected to susceptibility tests at 2 and 4 mg mL-1 of crude extracts (Table 6.2).  Based on 
this data, 2 mg mL-1 was selected as the sub-inhibitory concentration to be used. A sub-
inhibitory concentration was used since the goal was not to kill bacterial cells but rather 
attenuate their virulence abilities by inhibition of QS-regulated processes. 
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Table 6.2  Antimicrobial susceptibility of biosensors to V. ambigua and V. glaberrima 
extracts  
 Zone diameter (mm) 
 Hex DCM EA MeOH 
Conc. (mg mL-1) 2 4 2 4 2 4 2 4 
V. ambigua         
CV026 7 (R) 11 (I) 8 (R) 11 (I) 7 (R) 10 (R) 10 (R) 14 (I) 
ATCC 31532 0 (R) 0 (R) 0 (R) 11 (I) 0 (R) 0 (R) 0 (R) 0 (R) 
VIR07 7 (R) 11 (I) 8 (R) 10 (R) 7 (R) 10 (R) 10 (R) 14 (I) 
ATCC 12472 8 (R) 13 (I) 10 (R) 12 (I) 8 (R) 10 (R) 10 (R) 13 (I) 
V. glaberrima         
CV026 0 (R) 10 (R) 9 (R) 12 (I) 10 (R) 14 (I) 7 (R) 12 (I) 
ATCC 31532 0 (R) 0 (R) 0 (R) 0 (R) 0 (R) 10 (R) 0 (R) 0 (R) 
VIR07 0 (R) 12 (I) 9 (R) 12 (I) 7 (R) 10 (R) 10 (R) 14 (I) 
ATCC 12472 7 (R) 11 (I) 8 (R) 12 (I) 11 (I) 15 (S) 10 (R) 14 (I) 
Hex: hexane, DCM: dichloromethane, EA: ethyl acetate, MeOH: methanol 
When assessing the effect of V. ambigua crude extracts and 5,6-dehydrobrachycalyxolide 3 
on inhibition of short-chain C4-AHL and C6-AHL signal synthesis using the CV026/ATCC 
31532 system, only CviI (LuxI homologue in C. violaceum) inhibition was observed to 
varying degrees: VA-MeOH > VA-EA > 5,6-dehydrobrachycalyxolide 3 > VA-DCM 
(Figure 6.5A).  In the VIR07/ATCC 12472 assay (Figure 6.5B), CviI modulation (inhibition 
of long chain C10-AHL signal synthesis) was also observed in the following order: VA-DCM 
> 5,6-dehydrobrachycalyxolide 3 > VA-MeOH.  The VA-Hex extract was also able to inhibit 
CviR’ causing decreased pigmentation of the VIR07 sensor (Figure 6.5B).  The glaucolide 
5,6-dehydrobrachycalyxolide 3 potentially modulated the ability of the over-producer 
bacteria to synthesize both short and long chain AHL molecules, however, the strongest 
effect was observed for short chain AHL synthesis with VA-MeOH and VA-EA.  
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Figure 6.5  Quorum sensing inhibition at sub-inhibitory concentrations (2 mg mL-1) of 5,6-
dehydrobrachycalyxolide 3 and four Vernonia ambigua crude extracts; (A) modulation of 
AHL synthesis (LuxI); (B) modulation of AHL receptor activity (LuxR).  
 
When assessing the effect of V. glaberrima crude extracts and triterpenoids lupeol 1 and 
lupeol acetate 2 on inhibition of short-chain C4-AHL and C6-AHL signal synthesis using the 
CV026/ATCC 31532 system, both CviI (LuxI homologue in C. violaceum) and CviR 
inhibition was observed.  CviI inhibition was observed to varying degrees in the following 
order: lupeol 1 > VG-DCM > lupeol acetate 2 > VG-Hex (Figure 6.6A).  CviR inhibition 
was also observed with VG-DCM and VG-Hex, suggesting that compounds in these extracts 
are able to inhibit both AHL synthesis and reception.  In the VIR07/ATCC 12472 assay 
(Figure 6.6B), CviI modulation (inhibition of long chain C10-AHL signal synthesis) was also 
observed in the following order: lupeol 1 > VG-DCM > VG-Hex > lupeol acetate 2 > VG-EA 
> VG-MeOH. 
 
These two scenarios might provide an explanation for the CviI inhibitory activity: 
phytochemicals within the crude extracts or the purified compounds themselves either 
decrease the expression of the CviI synthase, which synthesizes the AHL molecules, or 
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decrease AHL synthesis due to their ability to competitively or non-competitively inhibit CviI 
activity (Vattem et al., 2007; Mihalik et al., 2008).  Secretion of molecules by higher plants 
that mimic AHL signal molecules allows a plant to regulate its associated bacterial 
populations, due to the limiting activity of pathogens by affecting AHL-regulated behaviors 
or by activating protection by plant growth-promoting-bacteria (Teplitski et al., 2011).  It is 
highly likely that 5,6-dehydrobrachycalyxolide 3 is an AHL mimic, which competitively 
inhibits CviI activity.   
 
 
Figure 6.6  Quorum sensing inhibition at sub-inhibitory concentrations (2 mg mL-1) of lupeol 
1, lupeol acetate 2 and the four Vernonia glaberrima crude extracts; (A) modulation of AHL 
synthesis (LuxI); (B) modulation of AHL receptor activity (LuxR) 
 
6.3 Experimental 
General experimental procedures 
1H, 13C and 2D NMR data were recorded on Bruker AvanceIII 400 MHz and 600 MHz 
spectrometers. The spectra were referenced according to the deuteriochloroform signals at δH 
7.24 and δC 77.0 and dimethyl sulfoxide δH 2.50 and δc 39.51 (for 1H NMR and 13C NMR 
spectra, respectively). Samples were acquired with deuterated chloroform (CDCl3) and 
dimethyl sulfoxide (DMSO-d6).  IR spectra were recorded using a Perkin Elmer Universal 
ATR spectrometer. Optical rotations were measured at room temperature on a Perkin 
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ElmerTM Model 341 Polarimeter with a 10-cm flow tube. UV spectra were obtained on a 
Varian Cary UV-VIS spectrophotometer. Melting points were determined on an Ernst Leitz 
Wetziar micro-hot stage melting point apparatus. Merck silica gel 60 (0.040–0.063 mm) was 
used for column chromatography and Merck 20 cm x 20 cm silica gel 60 F254 aluminium 
sheets were used for thin-layer chromatography (TLC). The TLC plates were analysed under 
UV (254 and 366 nm) before being sprayed and developed with anisaldehyde: concentrated 
sulfuric acid: methanol spray reagent (1:2:97). 
 
Plant material 
The aerial parts of V. ambigua (Kotschy and Peyr.) and the leaves of V. glaberrima (Welw. 
ex O.Hoffm.) were collected in March 2011 along Samaru to Giwa in Zaria, Kaduna State, 
Nigeria.  The plants were identified by Umar S. Gallah of the Herbarium, Department of 
Biological Sciences, Ahmadu Bello University, Zaria, Nigeria.  Voucher specimen numbers 
870 and 215, respectively were deposited for future reference.  
 
Extraction and isolation   
Dried aerial parts of V. ambigua (1.50 kg) and leaves of V. glaberrima (1.00 kg) were 
separately subjected to sequential extraction with hexane (Hex), dichloromethane (DCM), 
ethyl acetate (EtOAc) and methanol (MeOH) for 12 h on a shaker (Labcon, South Africa). 
All extracts were filtered and concentrated under reduced pressure on a rotary evaporator 
(Buchi Rota vapor R-210) at 25 ºC. The following yields for crude solvent extracts were 
obtained respectively for V. ambigua: (Hex: 12.50 g; DCM: 33.89 g; EtOAc: 19.25 g; MeOH: 




V. ambigua: The hexane extract of V. ambigua (10.20 g) was separated by column 
chromatography with a Hex: DCM step gradient starting with 100% hexane and gradually 
increasing the polarity by 10% DCM every 500 mL until 100% DCM was reached.  Fraction 
52-54 yielded a white amorphous compound 1 (50 mg). The DCM extract (20.00 g) was 
separated similarly, but with a Hex: DCM: EtOAc step gradient.   Compound 2 (32 mg) was 
eluted with Hex:DCM (8:2) and purified with the same solvent system.  Compound 3 (28 mg) 
eluted with 100% EtOAc and was purified with Hex: EtOAc (1:1).  The MeOH extract of V. 
ambigua (20.00 g) was dissolved in distilled water (200 mL), filtered and partitioned with an 
equal amount of n-butanol. The n-butanol fraction (100 mg) was subjected to column 
chromatography on Sephadex LH-20 (1.5 cm diameter column) using MeOH and collecting 
10 mL fractions. Compound 4 (10 mg) eluted in fractions 18-25 and was purified on a silica 
column using Hex: EtOAc (1:1).   
 
V. glaberrima: The hexane leaf extract (20.04 g) was separated by column chromatography 
with a Hex: DCM gradient as above. Fraction 22-26 yielded a white amorphous compound 1 
(45 mg). The DCM extract (18.00 g) was separated as above with a Hex: DCM: EtOAc step 
gradient.  Compound 2 (32 mg) eluted with hex:DCM (1:1) and was recrystallized from 
MeOH.  The methanol extract of V. glaberrima: (18.00 g) was partitioned with n-butanol as 
above and subjected to column chromatography on Sephadex LH-20 (1.5 cm diameter 
column) using MeOH and collecting 10 mL fractions. Fractions 12-42 were combined and 
further purified on a silica column using Hex: EtOAc (1:1), collecting 10 mL fractions, where 
fr. 14-28 afforded a yellowish compound 5 (12 mg), fr. 37-41 compound 6 (18 mg) and fr. 





(hydroxymethyl)acrylate (5,6-dehydrobrachycalyxolide) (3) white solid (28 mg); m.p.  92-93 
°C; [α]D20 +62° (c. 0.1 CHCl3); IR υmax (cm-1) 3468 (OH), 1755 (C=O); 1H NMR (400 MHz, 
CDCl3) δ  6.70 (1H, q, J = 7.2 Hz, H-17), 6.37 (1H, s, H-24a), 6.06 (1H, s, H-5), 6.02 (1H, 
bs, H-24b), 5.95 (1H, bs, H-8), 4.95 (1H, d, J =12.5 Hz, H-13a), 4.91 (1H, d, J =12.5 Hz, H-
13b), 4.35 (2H, s, CH2-25), 2.65-2.80 (2H, m, H-3α, H-9β), 2.45-2.65 (2H, m, CH2-2), 2.37-
2.45 (2H, m, H-3β, H-9α), 2.32 (3H, d, J = 7.2 Hz, CH3-18), 2.08 (3H, s, CH3-21), 1.50 (3H, 
s, CH3-15), 1.34 (3H, s, CH3-14); 13C NMR (100 MHz, CDCl3) δ 170.4 (C-20), 167.24 (C-
19*), 167.16 (C-12*), 165.5 (C-22), 152.1 (C-7), 147.9 (C-6), 144.0 (C-17), 138.3 (C-23), 
131.9 (C-16), 127.9 (C-24), 126.4 (C-11), 124.3 (C-5), 89.5 (C-1), 83.4 (C-4), 77.2 (C-10), 
65.9 (C-8), 61.9 (C-25), 55.6 (C-13), 41.8 (C-9), 39.7 (C-3), 32.9 (C-2), 31.8 (C-15), 23.6 (C-
14), 20.9 ( C-21), 14.6 (C-18). 
sample decomposed before elemental analysis and mass spectrometry could be carried out; * 
assignments may be interchanged 
 
Antibacterial susceptibility testing 
Antibacterial efficacy of crude extracts was assessed against four Gram-positive 
(Staphylococcus aureus ATCC 29213, methicillin-resistant Staphylococcus aureus ATCC 
43300 (MRSA), Staphylococcus xylosus ATCC 35033 and Staphylococcus sciuri ATCC 
29062) and four Gram-negative (Escherichia coli ATCC 25922, β-lactam resistant 
Escherichia coli ATCC 35218, Pseudomonas aeruginosa ATCC 27853 and Pseudomonas 
aeruginosa ATCC 35032) indicator bacteria using the disc diffusion method (CLSI, 2012).  
Crude extracts were dissolved in DMSO to a final concentration of 100 mg mL-1.  Blank 
discs (6 mm; MAST, UK) were impregnated with 4 mg of the pure compounds or crude 
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extracts and allowed to dry.  Indicator bacteria were grown overnight at 37 °C on Tryptic soy 
agar plates and re-suspended to a turbidity equivalent to that of a 0.5 McFarland standard.  
Suspensions were used to inoculate Mueller-Hinton (MH) agar plates by streaking swabs 
over the entire agar surface followed by the application of the respective extract/lactone discs.  
Plates were then incubated for 24 h at 37 °C.  Tetracycline (TE30 – 30 µg) and ampicillin 
(AMP10 – 10 µg) discs (Oxoid, UK) were used as standard antimicrobial agent controls, 
while DMSO-impregnated discs were used as negative controls. Antibacterial activity was 
determined by measuring the diameter of the inhibition zone (clear zone) formed around the 
well in mm and classified as follows: Resistant (R): ≤ 10 mm; Intermediate (I): 11-14 mm; 
Sensitive (S): ≥ 15 mm (Chenia, 2013).  The criteria for assigning susceptibility or resistance 
to AMP10 was as follows: (S) ≥ 17 mm, (I) = 14-16 mm, (R) ≤ 13 mm, while those for TE30 
were: (S) ≥ 19 mm, (I) = 15-18 mm, (R) ≤ 14 mm (CLSI, 2012).  Experiments were 
conducted in duplicate and averaged.   
 
Quantitative anti-quorum sensing activity-violacein inhibition 
The QS inhibitory properties of compounds 1-3, along with V. ambigua and V. glaberrima 
crude extracts were quantified using the violacein inhibition assay.  Inhibition of the C. 
violaceum ATCC 12472 purple pigment, violacein, was indicative of anti-quorum sensing 
activity (McLean et al., 2004).  Chromobacterium violaceum ATCC 12472 was cultured 
overnight in 5 mL of Luria-Bertani (LB) broth at 30 °C with or without crude extracts and 
compounds 1-3 in a concentration range of 0-9.5 mg mL-1.  QS inhibition (QSI)-positive 
control, cinnamaldehyde (Sigma, Germany) was tested at concentrations of 0.008-2 mg mL-1.  
One mL of culture was aliquoted and centrifuged at 13 000 rpm for 10 min.  The culture 
supernatant was discarded and the resulting pellet of precipitated violacein re-solubilised in 1 
mL DMSO, followed by centrifugation at 13 000 rpm for 10 min to precipitate the cells.  The 
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supernatant was aliquoted (1 mL) and violacein quantified using a UV-1800 UV-VIS 
spectrophotometer (Shimadzu, Japan) at a wavelength of 585 nm.  Testing was done in 
duplicate on two separate occasions.  The following formula was used to calculate the 
percentage of violacein inhibition: percentage of violacein inhibition = (control OD585 nm - 
test OD585 nm / control OD585 nm).  Differences in violacein inhibition mean values between 
extracts were determined using one-way repeated measures and ANOVA (SigmaStat 3.5; 
Systat Software Inc., San Jose, CA, USA) with p ≤ 0.05 being considered significant. To 
isolate the extract or extracts that differed from the others, the Holm-Sidak multiple pairwise 
comparison procedure was carried out with p ≤ 0.05 considered significant (Chenia, 2013). 
 
Qualitative modulation of QS activity 
The antibacterial efficacy of compounds 1-3 and V. ambigua and V. glaberrima crude 
extracts against biosensor system strains (biosensors C. violaceum CV026 and VIR07 and 
over-producers C. violaceum ATCC 12472 and ATCC 31532) was determined using the disc 
diffusion method (CLSI, 2012).  This was done to ensure that a sub-inhibitory concentration 
was used in the modulation assay in order to eliminate bactericidal effects. The modulation of 
AHL activity and inhibition of AHL synthesis by V. ambigua and V. glaberrima crude 
extracts and compounds 1-3 were determined using agar diffusion double ring assays (Vattem 
et al., 2007) at sub-inhibitory concentrations (2 mg mL-1).  The effect on short chain AHL 
inhibition was investigated with the C. violaceum biosensor system consisting of biosensor 
strain CV026 and C. violaceum ATCC 31532 as the C6-AHL over-producer (McClean et al., 
1997).  The long chain C. violaceum biosensor system consisted of biosensor strain VIR07 
and C. violaceum ATCC 12472 as the C10-AHL over-producer (Morohoshi et al., 2008).   
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Compounds 1-3, V. ambigua and V. glaberrima crude extracts, at sub-inhibitory 
concentrations (2 mg mL-1), were impregnated onto sterile filter paper disks and the AHL 
over-producer and biosensor strains were inoculated in concentric circles in proximity to the 
impregnated disks (Chenia, 2013).  Potential LuxI homologue inhibition was assessed by 
placing the AHL over-producer in close proximity to the test substance and the AHL 
biosensor distally.  LuxR homologue inhibition was assessed by reversing the location of the 
AHL over-producer and biosensor strains.  Modulation was inferred by observation of a 
lower signal from the AHL biosensor than from the over-producer (Vattem et al., 2007).  
Discs impregnated with cinnamaldehyde (2 μg) and water were used as positive and negative 
controls, respectively. 
 
6.4 Conclusion  
A new glaucolide sesquiterpenoid (5,6-dehydrobrachycalyxolide 3) was isolated from the leaf 
extract of V. ambigua.  This compound provides evidence of the biosynthetic pathway from 
brachycalyxolide to 5,6-dehydrobrachycalyxolide.  The quorum sensing inhibitory activities 
of lupeol 1, lupeol acetate 2 and 3 as well as V. ambigua and V. glaberrima crude extracts 
have demonstrated varying degrees of QS inhibition. The quantitative modulation of 
violaceum inhibition using the CV026 biosensor showed that 1, 2, and 3 at 2.6 mg mL-1 
showed an inhibition of ≥84%, while the crude extracts ranged from 61-92% at the same 
concentration. QS inhibition of isolated compounds 1-3, using the qualitative double ring 
assays showed predominant activity of the LuxI synthase homologue, which indicated that 
CviI was modulated by 1, 2 and 3, as well as V. ambigua and V. glaberrima crude extracts. 
The implication is that short chain QS signal synthesis was down-regulated or competitively 
inhibited. The long chain QS signal synthesis was also down-regulated or competitively 
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inhibited though to a lesser degree. This study has shown that V. ambigua, V. glaberrima and 
their compounds are potential sources of quorum sensing inhibitors.  
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CHAPTER 7 CONCLUSIONS AND RECOMMENDATIONS 
The four species of Vernonia studied in this work, V. ambigua, V. blumeoides, V. glaberrima 
and V. perrottetii are herbal remedies for infectious diseases in Nigerian traditional medicine. 
Species of Vernonia are rich sources of sesquiterpene lactones, a class of compounds 
associated with pharmacological activity.  The four Vernonia species were therefore 
subjected to phytochemical analysis in order to search for novel sesquiterpenes and identify 
lead compounds as antibacterial agents.  Novel compounds are often desirable in natural 
products research as bioactivty of known compounds are often contained in the literature.  
During the course of this work, our interests also shifted to testing the isolated compounds for 
their anti-quorum sensing ability, since compounds having the ability to inhibit quorum 
sensing could potentially be future antibacterial agents. 
 
Phytochemistry 
From our phytochemical analysis of these species of Vernonia, we isolated sesquiterpene 
lactones from three of the four plants studied, V. blumeoides, V. perrottettii and V. ambigua.  
Only V. glaberrima did not yield any sesquiterpene lactones.  This indicated that species of 
Vernonia are sources of sesquiterpene lactones, which could also serve as a chemotaxonomic 
marker for this genus.  In total, seven sesquiterpene lactones were isolated, six of which were 
novel.  V. blumeoides yielded four novel compounds of the eudesmanolide skeleton 
(blumeoides A-D), V. perrottetti yielded one novel keto-hirsutinolide compound (13-acetoxy-
1(4β),5(6)β-diepoxy-8α-(senecioyloxy)-3-oxo-1,7(11)-germacradiene-12,6-olide B1) in 
addition to a known keto-hirsutinolide (13-acetoxy-1,4β-epoxy-8α-(senecioyloxy)-3-oxo-





Figure 7.1  Sesquiterpene lactones isolated from Vernonia in this work 
 
The four blumeoidolides A-D were all related and make up a good biosynthetic pathway 
themselves, blumeoidolides A and B being acetyl derivatives of blumeoidolide C and 
blumeoidolide D being the oxidised biosynthetic product of blumeoidolide C.  It may be 
highly probable that further investigation of the same species at a different time may lead to 
the isolation of the di-acetylated blumeoidolide C and that acetylated forms of blumeoidolide 
D may also occur, although, different location and age of plant may be a considered factor.  
The novel compound B1 is the epoxidised form of B2 and 5,6-dehydrobrachycalyoxilde 
forms a biosynthetic link between brachycalyxolide and isobrachycalyxolide. 
 
Whilst searching for sesquiterpene lactones, several flavonoids were also isolated in the 
process, all of which were hydroxylated, and it must be noted that this genus is also rich in 
hydroxylated flavonoids that are well known for their antioxidant properties.  In addition, the 
ubiquitous sterols (lupeol, lupeol acetate and stigmasterol) were isolated from some of the 
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plants studied.  It is well documented that these sterols have immune boosting properties 
amongst other pharmacological effects. 
 
Antibacterial activity 
Selected sesquiterpene lactones (based on availability of sample) were tested for their 
antibacterial activity, by both the conventional disc diffusion method and quorum sensing 
inhibition (QSI) assay using the Chromobacterium violaceum CV026 and CV-VIR07 
biosensors.  Several of the sesquiterpene lactones showed good QSI in the assays.  QSI at 
approximately 80% was shown by blumeoidolide A (at  ≥ 0.071 mg mL-1), blumeoidolide B 
(≥ 3.6 mg mL-1), B1 (1.31 mg mL-1), B2 (0.33 mg mL-1) and 5,6-dehydrobrachycalyxolide 
(2.6 mg mL-1).  The sterols, lupeol and lupeol acetate, all had QSI ≥ 84% at 2.6 mg mL-1.  In 
silico docking studies with blumeoides A-D in the binding sites of quorum sensing regulator 
proteins CviR and CviR' indicated that these molecules bind to certain domains of these 
proteins, thus eliciting a response.   
 
Thus, the sesquiterpene lactones and sterols isolated from the different Vernonia plants may 
be lead compounds, which could be developed further into antibacterial drugs.   
 
Future work 
Since the sesquiterpene lactones isolated from Vernonia in this work were isolated in small 
amounts, more of the compounds need to be extracted or a method to synthesise them needs 
to be developed in order to test them against an array of bioassays, such as anticancer, anti-
HIV and anti-TB assays.  Cytotoxicity studies also need to be carried out on these compounds 
to determine whether or not they are viable candidates for the pharmaceutical industry.  
